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ABSTRACT 
 
Background: The recent development of detachable platinum coils means that they now represent an 
alternative method to surgery in the treatment of intracranial aneurysms which avoids surgical trauma 
to the brain. Currently no prospective randomized studies have compared these two modalities of 
treatment. 
Patients and methods: 109 consecutive patients with acute (<72h) aneurysmal subarachnoid 
hemorrhage (SAH) were randomly assigned to either endovascular (n = 52) or surgical (n = 57) 
treatment. Follow-up angiography was scheduled after clipping and 3 and 12 months after 
endovascular treatment. Clinical and neuropsychological outcomes were assessed 3 and 12 months 
after treatment; magnetic resonance imaging (MRI) of the brain was performed at 12 months. 
Hemodynamics and gastric intramucosal pCO2 were measured during the first 4 hours and between 6 
and 12 hours after aneurysm treatment in a sample of 26 patients. Cerebral perfusion was measured 
both before and one week after treatment by using 99mTc-ECD and single photon emission computed 
tomography (SPECT). 
Results: Significantly better primary angiographic results were achieved after surgery in patients with 
ACA aneurysm (n = 55, P = 0.005) and after endovascular treatment in those with posterior circulation 
aneurysm (n = 11, P = 0.045). The technique-related mortality rate was 2% in the endovascular group 
and 4% in the surgical group. The overall gastric intramucosal-arterial pCO2 difference (pCO2 gap) 
and gastric intramucosal pH (pHi) remained stable. Furthermore, there were no differences in pCO2 
gap or pHi between treatment groups or Hunt&Hess grade groups during the study period. In the 
visual comparison between the first and second SPECT the number of new or enlarged deficits (P = 
0.006), and deficits which expanded from being unilateral to bilateral (P = 0.020) significantly 
increased in the surgical group, but not in the endovascular group. In the semiquantitative evaluation 
of the second SPECT, surgical patients had regional abnormalities in the right frontobasal cortex when 
compared to the endovascular patients and in the ipsilateral frontobasal cortex and ipsilateral temporal 
apex when compared to contralateral side of the ruptured aneurysm. 
In the intention to treat analysis at the one year outcome, 41 endovascular / 43 surgical patients had 
good or moderate recovery, 4/5 had severe disability or were in a vegetative state and 7/9 were dead. 
Those patients with good clinical recovery did not differ in their neuropsychological test scores. 
Symptomatic vasospasm, poorer Hunt&Hess grade, need for permanent and larger size of the 
aneurysm independently predicted worse clinical outcome regardless of the treatment modality. In 
MRI, superficial brain retraction deficits and ischemic lesions in the territory of the ruptured 
intracranial aneurysm were more frequent in the surgical group. Kaplan-Meier analysis (mean follow-
up 39±18 months) revealed equal survival in both treatment groups. There were no occurrences of late 
rebleedings. 
Conclusion: In selected patients with acutely ruptured intracranial aneurysms, endovascular treatment 
provides a feasible method of treatment. Surgery achieves better primary angiographic occlusion rates 
in most anterior circulation aneurysms while aneurysms in the posterior circulation are better treated 
with coils. Splanchnic tissue perfusion may be insufficient after SAH though this is independent on the 
modality of treatment or pre-treatment Hunt&Hess grade. Progression of perfusion deficits is more 
common in the surgical group than in the endovascular group. One-year clinical and 
neuropsychological outcomes seem to be similar after either modality of treatment, even though 
endovascular treatment is significantly less often associated with MRI-detectable brain injury. 
Repeated angiographic controls are needed to ensure the stability of the endovascular occlusion. The 
long-term efficacy of endovascular treatment in the prevention of rebleeding remains open. 
 
National Library of Medicine Classification: WL 200, WL 355, WL 368 
Medical Subject Headings: subarachnoid hemorrhage/therapy; aneurysm, rupture; intracranial 
aneurysm/surgery; embolization, therapeutic; human; comparative study; treatment outcome; 
randomized clinical trials; follow-up studies; perfusion, regional; splanchnic circulation; tomography, 
emission-computed, single-photon; magnetic resonance imaging; neuropsychological tests 
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INTRODUCTION 
 
Aneurysmal subarachnoid hemorrhage (SAH) is sudden and often catastrophic event 
with a 50% mortality (71, 235). Recent improvements in the management of patients 
with aneurysmal SAH, may have slightly decreased the case fatality rates during the 
last decades (106). However, it is known that only 60% of patients with aneurysmal 
SAH reaching neurosurgical care actually recover to lead a normal life (236), and 
more than 20% of patients still die (135, 236, 238). In USA it is estimated that SAH 
accounts over 25% of all stroke-related years of potential life lost before age 65 
(124). In Finland, the incidence of primary SAH (19.5-23.4/100.000/year) is almost 
three times higher than in most parts of the world as reviewed by Linn et al. (161), 
and thus it is of our special interest to find a way to improve the outcome of these 
patients. 
A ruptured intracranial aneurysm carries a high risk of rebleeding with a case-
fatality rate of approximately 70% (199, 284), The risk of rebleeding with conservative 
therapy has found to be highest (4%) on the first day after SAH. It then remains 
constant at a rate of 1% to 2% per day during the subsequent two weeks (134). 
Thus, the primary aim of treating intracranial aneurysms is to prevent rebleeding by 
eliminating the intracranial aneurysm from the circulation while preserving blood flow 
through parent and branch vessels. Delayed cerebral deficit (DID) due to cerebral 
vasospasm (VSP) following aneurysmal SAH is the second major determinant of 
poor clinical outcome. It is the cause of death or disability in 14 % of the patients who 
reach neurosurgical care within three days after hemorrhage (135). The most 
common time for the appearance of DID is between day 4 and day 14 after SAH 
(276, 277). Thus, the secondary aim of securing a ruptured intracranial aneurysm is 
to permit aggressive medical or interventional treatment of arterial VSP to prevent or 
reverse this delayed ischemia (10, 59). 
Traditionally the application of a spring clip across the neck of an aneurysm has 
been considered as the best way to eliminate an aneurysm from the circulation (38, 
50, 52, 289, 290). Open surgery is often demanding because of the fragile and 
swollen brain, which is covered by a thick layer of blood in the acute stage of SAH. 
Manipulation of the brain and cerebral arteries during surgery may cause structural 
damage to the brain tissue, induce VSP and increase the frequency of delayed 
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cerebral ischemia (94, 101, 224, 282). To avoid these problems, several 
endovascular methods of treating ruptured intracranial aneurysms have been 
developed since 1970’s (43, 51, 78, 104, 227, 239). In 1991, Guglielmi et al. (88, 90) 
introduced an electrically detachable platinum coil system (Guglielmi detachable 
platinum coil (GDC)) that permitted endovascular occlusion of the aneurysm and 
readjustment of the coil position before final detachment.  
Clinical trials have shown GDC treatment to be efficient in preventing 
rebleeding, and improving the clinical outcome in comparison to simple conservative 
treatment of ruptured intracranial aneurysms (24, 27, 145, 216, 285). However, 
comparisons at recent surgical series (96, 101, 135, 136, 198, 236, 238, 291) with 
most endovascular series (24, 27, 145, 216, 285) have encountered a considerable 
bias concerning the nature of the population characteristics and the timing of the 
treatment after SAH. However, some data do suggest that endovascularly treated 
patients with ruptured intracranial aneurysms have a tendency towards suffering less 
neuropsychological impairment and less structural brain damage in comparison to 
the surgically treated patients (94). 
One of the major concerns about endovascular therapy is the long-term efficacy 
of the treatment. In a recent systematic review of endovascular series, complete 
occlusion was achieved in only half of the ruptured intracranial aneurysms (20). 
Furthermore, occlusion of the coiled aneurysms is frequently unstable with a reported 
recanalization rate of 28% to 46% (98, 257). A recent series by Byrne et al. (24) 
reported a rebleeding rate of 7.9% in the aneurysms with an unstable occlusion 
during a median of 22.3 months follow-up indicating the need for long-term 
angiographic follow-up of the coiled aneurysms.  
The severity of the initial bleeding and the clinical condition of the patient after 
bleeding are the most important factors predicting clinical outcome (101, 135, 189). 
However, medical complications after aneurysmal SAH may have a significant effect 
on the overall mortality rate (101, 135, 136, 149, 244, 293). Insufficient splanchnic 
tissue perfusion has been regarded as one of the possible mechanisms being 
responsible for the development of systemic medical complications (7, 155). 
Increased levels of catecholamines or cytokines may cause vasoconstriction in the 
splanchnic area and lead to deterioration of splanchnic tissue perfusion (241, 279). 
High levels of catecholamines in plasma have been found in patients with SAH (47). 
There is evidence that splanchnic ischemia occurs commonly in isolated 
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neurotrauma, with a trend toward development of mucosal ischemia accompanied by 
decreased cerebral perfusion (279). However, there are no studies about this issue 
concerning the patients with SAH. In theory, open surgery of the ruptured aneurysm 
is more traumatic to the brain than endovascular therapy, and would be predicted to 
be more likely to induce splanchnic hypoperfusion. 
Although VSP is one of the major determinants of a poor outcome, the 
appropriate diagnosis before the irreversible delayed ischemic changes have 
developed remains problematic, especially in patients with impaired consciousness 
(48, 144). Clinical suspicion of VSP may be confirmed by directly addressing the 
effects of VSP on the regional cerebral blood flow (rCBF). In recent studies, 
semiquantitative single photon emission computed tomography (SPECT) has 
provided important data for detecting VSP (40, 207, 245).  
The high incidence of SAH in Finland, the defined catchment area (900,000 
people) with no referral bias, and the experience with early surgery (100, 101, 189) 
allowed us to design and conduct this prospective randomized study of the 
treatment of recently ruptured (<72 hours) intracranial aneurysms either by GDC 
occlusion or by conventional surgical clipping. The main objectives of the study 
were to compare early safety, efficacy and outcome of endovascular and surgical 
therapy, and to determine the differences between these treatment modalities in 
long-term clinical, neuropsychological and radiological (angiographic occlusion 
rate; magnetic resonance imaging (MRI) of the brain) outcomes. Furthermore, the 
prospective setting of the study meant that it was feasible to evaluate with SPECT 
the differences in the cerebral perfusion before and after surgical or endovascular 
treatment as well as determining differences in splanchnic tissue perfusion, which 
was assessed by gastric tonometry immediately after endovascular or surgical 
treatment.  
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REVIEW OF THE LITERATURE 
 
1. Subarachnoid hemorrhage 
 
SAH is a medical emergency. The typical clinical presentation of SAH is a sudden 
and severe headache. The onset of headache may be associated with a brief loss of 
consciousness, nausea and/or vomiting, focal neurological deficits or stiff neck (172). 
Despite the typical clinical features of SAH the differential diagnosis especially with 
other acute diseases presenting with headache can be difficult (269). A minor leak 
with a sudden transient headache can precede the major bleeding in 20-37% of 
cases, and recognition of this “warning sign” may increase the chances of the patient 
to enjoy a favorable outcome (121, 125).  
 
1.1. Incidence of primary subarachnoid hemorrhage 
 
Primary SAH is defined as a bleeding, which takes place primarily in the intracranial 
subarachnoid space, and is not a secondary manifestation of some other disease 
(199). In a recent systematic review of the literature, the worldwide overall incidence 
of SAH was 10.5. per 100.000 person years (269). However, taking into account the 
fact that the incidence in Japan was 23.0 / 100 000 person years and in Finland 22.0 
/ 100 000 person years, the incidence in other parts of the world was only 7.8 / 100 
000 person years. The overall incidence of aneurysmal SAH has remained constant 
during the last decades (161), but increases almost linearly with increasing age (71). 
However, the mean age of death in patients with SAH (59 years) is considerably 
lower than for ischemic stroke (81 years). In the United States, SAH accounts for only 
4% of stroke mortality but over 25% of all stroke-related years of potential life lost 
before age 65 (124).  
 
1.2. Etiology of subarachnoid hemorrhage 
 
The cause for primary SAH is rupture of an intracranial aneurysm in more than 80% 
of cases (237, 269). SAH of unknown origin represents 9% to 15% of cases (135, 
228). In these cases, the pattern of bleeding is different from the aneurysmal type of 
bleeding. Typically, the maximum amount of blood is found anterior to the pons with 
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possible extension to the ambient cisterns or to the basal parts of the Sylvian fissures 
(223). The source of the bleeding of unknown origin can be a rupture of small 
perforating artery or a micro- arteriovenous malformation (AVM), which is not 
identifiable in diagnostic imaging (228). Intracranial artery dissections, cerebral 
AVMs, dural AVMs, trauma, bleeding disorders, substance abuse, a spinal origin of 
the hemorrhage and other rare conditions account for primary SAH in less than 5% of 
cases (269). 
 
1.3. Intracranial aneurysms 
 
An aneurysm is a persistent localized dilatation of the vessel wall. Saccular 
aneurysms account for the vast majority (98%) of all intracranial aneurysms. Other 
types of aneurysms are arteriosclerotic ectatic aneurysms (fusiform in shape), 
dissecting aneurysms, infectious (mycotic) aneurysms and traumatic aneurysms 
(289).  
Aneurysms seem to be acquired lesions. Hemodynamic stress upon the arterial 
bifurcations and pathological changes in vessel wall predispose to aneurysm 
formation. Factors that alter blood flow, such as vessel occlusions, arteriovenous 
malformations, hypertension and connective tissue diseases may accelerate the 
degenerative process (275, 278). 
Intracranial aneurysms are reported to be present in 1% to 5% (range, 0.2% to 
8.0%) of the general population (230). The prevalence figures are clearly related with 
the study method. The true prevalence of intracranial aneurysms remains unknown. 
In large forensic clinical and autopsy series, the locations of intracranial aneurysms 
are internal carotid artery (ICA) (24% - 41%), anterior cerebral artery (ACA) (30% - 
39%), middle cerebral artery (MCA) (20% - 33%) and vertebrobasilar arteries (VBA) 
(4% - 12%) (278). In our consecutive series of 1314 patients before the era of 4-
vessel studies, the corresponding figures were ICA (23%), ACA (30%), MCA (39%) 
and VBA (7%) (224). The predominance of MCA aneurysms is often reported in other 
Finnish series (71, 199). In Finnish series, up to one third of the intracranial 
aneurysms are multiple, which has become a common clinical therapeutic problem 
(224, 225). 
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1.4. Risk factors for aneurysmal subarachnoid hemorrhage 
 
Cigarette smoking, large size of the unruptured intracranial aneurysm, advanced age, 
hypertension and alcohol abuse have been recognized as risk factors for SAH (126, 
127, 254). Female gender has also been recognized to predispose towards SAH but 
only in the age group of over 40 years. This has been suggested to be related with 
hormonal factors (142). In the historical Finnish series of Pakarinen (199), females 
outnumbered males in all age groups, though only slightly in the age groups under 60 
years. However, in recent Finnish series, males are more often affected (101, 224, 
235). 
There is evidence that genetic factors are associated with the predisposition for 
SAH. In east Finland, approximately 10% of aneurysmal SAH patients have a positive 
family history of aneurysmal SAH or incidental intracranial aneurysms, with at least 2 
affected first-degree family members (229). Within familial SAH families, the risk for 
harboring intracranial aneurysms among asymptomatic family members is at least 4 
times higher than in sporadic SAH families (230). Familial intracranial aneurysms 
seem to rupture at an earlier age than their sporadic counterparts and they may be 
smaller when they rupture. The occurrence of aneurysmal SAH is also associated 
with some rare heritable connective tissue disorders such as autosominal dominant 
polycystic disease, Ehlers-Danlos syndrome type IV, neurofibromatosis type I and 
Marfan’s syndrome (237). 
 
2. Natural history of ruptured intracranial aneurysms  
 
With conservative treatment, the outcome of aneurysmal SAH is not very impressive. 
According to a historical unselected series of 363 patients with ruptured intracranial 
aneurysms reported by Pakarinen (199) there was a 15% mortality prior to hospital 
admission and a mortality of 32%, 46%, 56% and 60% at day 1, week 1, month 1 and 
month 6, respectively.  
 
2.1 Factors that influence prognosis 
 
The overall outcome of SAH patients is dependent on the severity of the 
hemorrhage, the initial posthemorrhage clinical condition of the patient and the 
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occurrence of subsequent events such as rebleeding, VSP, hydrocephalus, medical 
complications and complications of therapy (72, 135, 164, 189, 244). Prognostic 
factors for mortality are: decreased level of consciousness at admission, increased 
age, thick clot of blood on initial CT scanning, hypertensive disease, other pre-
existing medical illnesses, large aneurysm and aneurysm located in the posterior 
circulation (101, 135, 150, 189). 
 
2.2. Rebleeding 
 
In the prospective Cooperative Aneurysm Study (134), the risk of rebleeding with 
conservative therapy was highest (4%) on the first day after SAH and then remained 
constant at the rate of 1% to 2% per day during the subsequent two weeks. In his 
earlier series, Pakarinen (199) reported a cumulative frequency of rebleeding of 7%, 
16%, 23% and 33% at week 1, week 2, week 3 and week 4, respectively. The 
cumulative incidence of recurrences within the first 8 weeks was 40% and within the 
first six months 43%. This is in accordance with the series by Locksley (163) in which 
the risk of recurrent bleeding was 30% within the first month and 40% within 6 
months after SAH. In the series of Pakarinen (199), the mortality at first recurrence 
was 63.6% and at second recurrence it had risen to 86%. According to Winn et al. 
(284) those who survive six months still have a risk of subsequent bleeding of 3% per 
year and the mortality from subsequent rebleeding is as high as 67% of cases. 
 
2.3. Grading methods for predicting outcome 
 
Fisher (70) grading method (Table 1) for estimating the amount of cisternal blood 
after SAH has been widely used (101, 135, 189, 236). The problem with the 
classification is that there are often interobserver disagreements (248).  
The most common system for grading the clinical condition after SAH is the 
Hunt and Hess (H&H) (114) scale (Table 1). In the original classification according to 
Hunt&Hess, patient grade was increased by one level in the presence of serious 
underlying medical disorders. On this scale, a higher grade at presentation correlates 
with increasingly poor clinical outcome. In 1987, the World Federation of Neurological 
Surgeons (WFNS) (218) proposed a new grading system (Table 1), in which two 
factors have been assigned to differentiate grades: consciousness level, classified 
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with the Glasgow coma scale (GCS) (253), and focal neurological deficits. A recent 
survey of published articles on SAH reported that from 1985 to 1992, 71% of authors 
used the H&H scale, 19% used the WFNS scale, and 10% used another scale to 
report the clinical results (268). Timing of the grading is important because the 
patient's worst clinical grade is the best predictor of outcome, especially when the 
patient is assessed using the WFNS scale or the GCS (28).  
 
3. Methods for outcome assessment 
 
Many studies on outcome after aneurysmal SAH focus on the case-fatality rate (106, 
117). A large variety of grading systems have been advocated, however, outcome is 
still often graded in a robust way as “poor”, “fair”, or “good” (107). The most 
frequently specified outcome measures are the Glasgow outcome scale (GOS) (122) 
and the Rankin scale (212) of neurological disability, with scores ranging from 1 (no 
disability) to 5 (severe disability) (Table 1). These scales rely on physician-orientated 
global assessments. The facility with which these scales are administrated and 
recorded has made them popular instruments. However, there have been attempts 
towards more specific determination of functional outcome and quality of life (26, 
107, 194).  
It is not uncommon for patients classified as having good neurological outcome 
are found to experience with some deficits in higher mental function when this is 
tested by sensitive neuropsychological measures. Cognitive status may be 
determined with the Mini–Mental State Examination (73) only, but more accurate 
information of the mental sequel of SAH can be achieved by performing a pattern of 
special neuropsychological tests (17, 18, 94, 115, 116, 162, 174, 193, 194, 226, 
283). Especially sequel after rupture of an ACA aneurysm has been suggested to 
result in a poorer neuropsychological outcome than in the aneurysms at other sites 
(18). However, even modern neuropsychological tests may fail to demonstrate the 
potential neuropsychological impairment (4, 283). In practice, telephone interviews 
for cognitive status (282) may often replace the more comprehensive 
neuropsychological assessments. Late imaging studies may provide additional 
information of the extent of persisting brain tissue damage (94, 140, 283). However, 
normal cognitive functioning does not exclude pathological CT or MRI findings, and  
vice versa (226).
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Table 1. The most common clinical and radiological grading systems used after 
subarachnoid hemorrhage (SAH). 
 
Fisher classification (70) Blood on computed tomography 
   
Grade 1 No blood detected 
 2 Diffuse or vertical layers < 1mm thick 
 3 Localized clot and/or vertical layer ≥ 1mm thick 
 4 Intracerebral / intraventricular clot with  
Diffuse or no SAH 
  
Hunt & Hess Scale (114) Clinical findings 
   
Grade 0 No SAH 
 I Asymptomatic or mild headache, mild  
nuchal rigidity 
 II Moderate to severe headache, nuchal rigidity,  
no neurologic deficit, except cranial nerve palsy 
 III Drowsiness, confusion, or mild focal deficit 
 IV Stupor or mild to moderate hemiparesis;  
possible early decerebrate rigidity 
 V Deep coma, decerebral posturing, moribund 
  
World Federation of Neurosurgical 
Societies (WFNS) Scale (218) 
 
GCS* 
 
Motor deficit 
    
Grade 0 15 Absent and no SAH 
 1 15 Absent 
 2 13-14 Absent 
 3 13-14 Present 
 4 7-12 Present 
 5 3-6 Present or absent 
  
Glasgow Outcome Scale (122) Clinical findings 
   
Grade 5 Good recovery 
 4 Moderate disability (disabled but independent) 
 3 Severe disability (conscious but disabled) 
 2 Persistent vegetative state 
 1 Death 
  
Rankin Outcome Scale (212) Clinical findings 
   
Grade 1 No significant disability: able to carry out  
all usual daily routines 
 2 Slight disability: unable to carry out some  
previous activities but able to look after  
affairs without assistance 
 3 Moderate disability: requiring some help  
but able to walk without assistance 
 4 Severe disability: bedridden, incontinent and  
requiring constant nursing care and attention 
 
Note: *Glasgow Coma Scale (253) 
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4. Imaging studies 
 
4.1. Computed tomography 
 
If SAH is suspected, computed tomography (CT) scanning is the first diagnostic 
procedure to be undertaken (66, 172, 237, 269). If CT is performed within 24 hours of 
the bleeding, a high-density layer of blood can be seen in over 90% of cases. The 
sensitivity of CT declines after the first day and 5 days after the hemorrhage blood 
can be detected in less than 60% of patients with SAH (135). A lumbar puncture for 
analysis of spinal fluid should be performed in those cases where there is a negative 
CT scan. The diagnostic spinal tap is considered to be reliable if performed between 
12 hours and two weeks after the onset of headache (280). In addition to the 
diagnosis of SAH, the CT scan provides information of the severity and possible 
origin of the bleeding as well as the hydrocephalus, the mass effect caused by a 
hematoma and possible ischemic complications and other brain lesions. The 
localization of blood has been used with a variable success rate in order to identify 
the ruptured aneurysm in a case of multiple aneurysms (267).  
CT angiography (CTA) is based on the technique of helical CT. It requires only 
intravenous injection of contrast medium, being thus quicker and less invasive than 
conventional angiography. The technique provides a multidimensional view of the 
aneurysm and the adjacent structures including the bony landmarks, which is useful 
in any subsequent surgical procedures (5, 295). In the studies where CTA and 
conventional angiography have been compared, the sensitivity of CTA has been 
good (96-97%) and its specificity even better (90-100%) (5, 295). However, in small 
aneurysms (<5 mm) CTA is considered to be less reliable than conventional 
angiography (109). Further, difficulties may be encountered with aneurysms in 
proximity to the skull base (5). Recent series have indicated that good-quality CTA 
studies could be used as the only preoperative neuroimaging technique in a large 
proportion of patients with ruptured intracranial aneurysms at least in emergency 
situations (295). 
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4.2. Digital subtraction angiography 
 
Conventional cerebral angiography is the gold standard for aneurysm detection 
(269). However, it can be time consuming and it is invasive with a complication rate 
of 1.8-2.1% (31, 96). In addition it provides limited anatomical information of the 
actual geometry of the aneurysm or the adjacent vessels. Three dimensional 
rotational digital subtraction angiography (3-D DSA) allows a multidimensional 
visualization of the aneurysmal and a high resolution perspective of vascular 
anatomy (251). The intra-arterial injections have to be prolonged (>6 seconds) if one 
is to achieve arterial opacification during the entire C-arm movement. The relatively 
high volume of nonionic contrast material and the prolonged acquisition time has 
been found to be well tolerated (264). Recent advances in computing technology 
have shortened the time required for 3-D reconstruction and the images can be 
obtained within ten minutes after acquisition. Furthermore, a good correlation of 3-D 
DSA with surgical anatomy as well as usefulness of the novel technique in planning 
both endovascular and surgical procedures has been demonstrated (251). 
 
4.3. Magnetic resonance imaging 
 
The role of MRI in the early evaluation of SAH is limited (237). Technically it is 
possible to detect acute SAH with a special MRI technique (FLAIR, fluid attenuated 
inversion recovery) as reliably as with CT (190) but MRI tends to be impractical 
because it is time consuming and confused patients cannot be studied without 
sedation and assisted ventilation (269). However, in the subchronic stage of SAH, 
MRI is superior to CT in detecting subarachnoidal blood (192). In addition, diffusion-
weighted sequences can be used to detect ischemic complications more accurately 
than can be achieved CT (79). 
Noninvasive three-dimensional time-of-flight (3D-TOF) MRA has been found to 
be especially useful in the preprocedural evaluation of ruptured intracranial 
aneurysms with a complex anatomy. It is also useful in the assessment of 
thrombosed aneurysms. However, caution has to be advocated with respect to the 
small aneurysms and aneurysms located close to the skull base (3). The newly 
developed endovascular methods in treating intracranial aneurysms have stressed 
the need for a noninvasive method for long-term monitoring of the stability of 
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occluded aneurysms. 3D-TOF MRA with postprocessing using targeted maximum 
intensity projection (MIP) reconstructions seems to hold promise for this purpose. 
However, it is limited in its ability to detect the small aneurysm remnants (19, 129). 
 
5. Management of ruptured intracranial aneurysms 
 
The natural history of the ruptured intracranial aneurysms obligates an early 
treatment of these lesions. The goal of the treatment is to prevent rebleeding by 
occluding the ruptured aneurysm. In recent years the trend has been towards early 
treatment (within three days after SAH), although there is no conclusive evidence 
that this is truly beneficial (29, 66, 72, 135, 136, 195).  
 
5.1. Surgical repair of ruptured aneurysms  
 
The first surgeon to operate a ruptured intracranial aneurysm was Dott (50), in 1931, 
who packed the aneurysmal sac with muscle to reinforce the aneurysm wall. in 1938 
Walter Dandy (38) was the first to occlude an intracranial aneurysm by clipping its 
neck. In the1950’s ruptured intracranial aneurysms were diagnosed with angiography 
and treated operatively in many centers. However, in 1959, based on a retrospective 
detailed analysis of 599 either conservatively or operatively treated patients with 
angiographically proven ruptured intracranial aneurysms, McKissock et al. (175) 
concluded that although surgical treatment appeared to benefit patients when only 
gross mortality figures were considered, this was simply because only the better 
patients were selected for surgery. The conclusion was that if the populations of 
conservatively and surgically treated patients were similar, the mortality figures would 
be identical. In 1971 Troupp and af Björkestein (261) published their prospective 
controlled trial of late surgical versus conservative treatment of intracranial 
aneurysms involving 178 SAH patients of good clinical grade. They concluded that 
good grade patients have such a good natural prognosis that the value of late 
surgery appeared limited. 
The results of operative treatment were poor until the advances in neurosurgical 
techniques and neuroanesthesia in the late 1960’s allowed neurosurgeons to treat 
successfully the majority of intracranial aneurysms (52). The goal for surgical 
treatment of intracranial aneurysms is to eliminate the aneurysm from the circulation 
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while preserving blood flow through parent artery and branch vessels. This treatment 
is best accomplished by direct clip placement across the aneurysm neck.  
 
5.1.1. Technical aspects of surgical repair of ruptured aneurysms 
 
Surgical aneurysm operations are mostly performed under general anesthesia and 
using the microsurgery techniques introduced by Yasargil (289-291). 
Microneurosurgical instrumentation includes a microscope, a head fixation device, a 
self-retaining brain retractor, arm rest, bipolar coagulation, scissors with a smooth 
closing action, small caliber suction tip, high-speed drill and a variety of different 
aneurysm clips with their appliers (289). The clips for temporary occlusion of the 
parent artery have a low closing force in order not to cause permanent damage to the 
vessel wall. To achieve permanent clipping, there are multiple choices of clips in 
different sizes, shapes and closing forces. The modern clips are MRI compatible 
(202). 
An operative approach must take into account the location of the aneurysm and 
it should allow minimal brain retraction. According to Yasargil (289), the most useful 
approaches are: 1) pterional craniotomy for aneurysms of the anterior circulation and 
upper basilar artery, 2) paramedian frontal craniotomy for pericallosal artery 
aneurysms 3) lateral suboccipital craniotomy for the aneurysms of the vertebral 
circulation below the origin of the superior cerebellar arteries (289, 290). Drake (55), 
however, favored a subtemporal approach for most of his upper basilar artery 
aneurysms.  
Using gentle brain retraction the arachnoid cisterns are entered with sharp 
dissection and finally the aneurysm and the adjacent vessels are exposed with a 
meticulous dissection. Prior to application of the clip, the aneurysm neck must be free 
of adhesions to surrounding arteries and neural structures. In narrow necked 
aneurysms, the clip can be placed across the aneurysm neck. However, in complex 
aneurysms several clips may be needed to appropriately occlude the aneurysm in a 
stepwise manner (101, 289, 290). Although most aneurysms are amenable to 
clipping, their size, location, morphology, or the technical difficulties encountered may 
sometimes prevent the procedure. Alternative techniques for treating these unclipable 
aneurysms include proximal vessel occlusion with or without extracranial-intracranial 
(EC-IC) bypass, trapping, wrapping or excision of the aneurysm (55, 233, 246, 289, 
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290). Proximal endovascular balloon occlusion for unclipable aneurysms may provide 
a convenient and effective option of producing arterial occlusion (54). 
 
5.1.2. Timing of surgical treatment of ruptured aneurysms 
 
The optimal timing for surgical treatment of the acutely ruptured aneurysms was 
under constant investigation and a subject of major controversy during the 1980s (29, 
134-136, 195, 250). In the 1960s, operative treatment was still generally delayed 3 to 
4 weeks following SAH so that the brain could recover from the acute effects of SAH. 
However, mortality and morbidity during the waiting period was high because of 
occurrence of VSP and rebleeding (136). An operation during an early phase (within 
72 hours following SAH) or even during the acute phase (within 24 hours following 
SAH) was considered justifiable in order to prevent early rebleeding and allow 
aggressive treatment of VSP, and thus improve the outcome of the patients. 
The nonrandomized International Cooperative Study on the Timing of Aneurysm 
Surgery (135, 136) carried out between December, 1980, and July, 1983 did not find 
any major differences between the outcomes of the patients treated either with early 
(≤ 3 days) or delayed surgery (> 10 days). In contrast to these results, the North 
American Participants of the Cooperative Study (96) found evidence for early surgery 
in evaluating the data of patients treated in North America. In accordance with these 
results were the results achieved by early surgery simultaneously in Lund, Sweden 
and in Kuopio, Finland during the calendar year 1982 (272). The results of the only 
randomized study on timing of surgery by Öhman et al. (195) favored early surgery 
compared with surgery on days 4 to 7, with respect to the achievement of 
independence at the 3-month follow-up. However, in the overall outcome at 3 months 
after the SAH there was only a trend toward better results in the acute surgery group. 
In the population-based study of Fogelholm et al. (72) patients having undergone 
early surgical treatment had better functional outcome than those with delayed 
surgery. However, early surgery only marginally improved survival.  
Although the data available is not consistent, early surgery for patients in good 
preoperative clinical grade (Hunt&Hess Gr I-III) has gradually been accepted as 
treatment policy in many institutions (101, 195, 198, 236, 238). Delayed surgery for 
patients in poor preoperative clinical grade, however, may be advisable unless 
immediate surgical intervention is required because of large hematoma or severe 
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hydrocephalus (100, 101, 203). On the other hand, the results of recent systematic 
review of the literature published between 1974 and 1998 suggested that both early 
and intermediate surgical treatment can improve the outcome after SAH especially in 
good grade patients but to a lesser degree also in patients with poor preoperative 
grades (42). 
 
5.1.3. Outcomes in clinical trials on surgical treatment of ruptured aneurysms 
 
The results of management outcome in patients with aneurysmal SAH have not been 
reported in a standardized manner. The reports should include data on neurological 
condition at admission, other prognostic factors such as primary CT findings, and the 
overall management results (42). Another severe problem is the selection bias 
related in most of the surgical series, especially in those studies conducted in large 
referral centers (281). The following studies (101, 135, 136, 198, 236, 238) have 
been chosen to demonstrate the overall management results or surgical results in 
referral centers with an active admission policy allowing early treatment of ruptured 
aneurysms. The overall management outcomes (135, 136, 236, 238) and surgical 
outcomes (101, 135, 136, 198, 238) have been summarized in the Tables 2 and 3. 
The prospective International Cooperative Study on the Timing of Aneurysm 
Surgery (135, 136) studied patients treated between 1980 and 1983 (Table 2 and 3). 
Both the surgical and management outcomes were reported for a total of 3521 
patients. There was, however, a considerable selection bias since 5358 patients 
were excluded from the study, mainly because they were admitted more than 3 days 
post-SAH (46% of cases). Although more than 75% of the patients were admitted in 
good clinical condition, only 58% of the overall 3521 patients and 68% of the 
surgically treated 2922 patients were classified as being independent at the follow-up 
examination. Prognostic factors for poor clinical outcome were decreased level of 
consciousness due to the initial bleeding, thick layer of blood on admission CT, larger 
size of the aneurysm, advanced age (almost linearly), pre-existing medical conditions 
and higher blood pressure on admission. In terms of overall management results, 
patients with ACA and VBA aneurysms fared worse than patients with ICA or MCA 
aneurysms. However, this difference was not noted in the surgical results. Aside from 
the direct effects of the initial hemorrhage, VSP was the leading cause of unfavorable 
 
 
Table 2.  Management outcomes according to clinical grades, aneurysm sites and aneurysm sizes in the recent large series of 
surgical treatment of patients with acutely ruptured aneurysms including overall procedural morbidity / mortality rates. 
 
Outcome GOS (%) Outcome GOS (n%) 
Study 
Number of  
patients with 
SAH  
Average 
follow-up 
time 
Site of the ruptured 
Aneurysm  
n  (%) 
GR/MD SD/VS    Death
Hunt & Hess 
Grades  
(n / %) 
GR/MD SD/VS Death
 
Overall 
Morbidity / 
Mortality  
ICA 1051 (30) 68 8 24 I-II 1722 (49) 82 5 13 
MCA 786 (22) 72 7 21 III 1136 (32) 64 8 28 
ACA     1374 (39) 63 7 30
Kassell et al. 
 –90 (137, 138)
3521 
 
GOS at 
6-months 
VBA     203 (6) 61 8 31
IV-V 663 (19) 31 12 57 
16 % / 26 % 
ICA 40 (26) I-II 82 (53) 
MCA 23 (15) III 24 (16) 
ACA  76 (50)
Seiler et al.  
–88 (236) 153 
GOS at 
6-months 
 
VBA  
   
14 (9)
67 6 27
IV-V 47 (31) 
67 6 27 14 % / 27 % 
ICA       70 (21) GR 60 
MD-SD
29 
Death 
11 I-II 72 (50) 80 12 9
MCA 93 (29) 55 29 16 III 53 (16) 56 26 18 
ACA     136 (42) 59 17 24
Säveland et al. 
–92 (247) 
 
325 GOS at 12 months
VBA     26 (8) 38 12 50
IV-V 110 (34) 20 37 43 
23 % / 21 % 
 
(Procedural 
morbidity / 
mortality 7 %; 276 
had surgery)* 
 
Note: * Procedural morbidity and mortality fiqures are included because the surgical results could not be derived from this series for 
more detailed presentation as could be done from the series of Kassell et al. (137, 138) and Seiler et al. (236) (Table 3). 
MCA = middle cerebral artery, ACA = anterior cerebral artery, anterior communicating artery, pericallosal artery 
ICA = internal carotid artery, ophthalmic artery, posterior communicating artery, anterior choroidal artery, VBA = vertebrobasilar arteries 
GOS = Glasgow Outcome Scale (124) 
GR = good recovery, MD = moderate recovery, SD = severe disability, VS = vegetative state
 
Table 3. Surgical outcomes according to clinical grades, aneurysm sites and aneurysm sizes in the recent large series of patients with acutely 
ruptured aneurysms including overall and procedural morbidity / mortality rates. 
 
Outcome GOS (%) Outcome GOS (n%) Study 
Number of 
SAH patients 
with early 
surgery  
Average 
Follow-up 
Time 
Site of the 
ruptured 
Aneurysm  
n (%) 
GR/MD    SD/VS Death
Hunt & Hess 
Grades  
(n / %) 
GR/MD SD/VS Death
Overall 
Morbidity / 
Mortality (%) 
Procedure Related 
Morbidity / Mortality 
(%) 
ICA 882 (30) 79 8 13 I-II 1882 (64) 87 5 8 
MCA 707 (24) 80 7 13 III 727 (25) 72 9 19 
ACA 1104 (38) 76 7 17 
Kassell et al. –90 
(137, 138) 
1478 / 2922 
(51%) 
GOS at 
6-months 
VBA 190 (7) 78 10 12 
IV-V     313 (11) 39 22 39
18  /  14  
3.5 – 10.0  
(according to 
timing of surgery, 
not reported in 
detail) 
ICA 34 (30) I-II 77 (66) 
MCA 20 (17) III 19 (17) 
ACA 53 (46) 
Seiler et al. –88 
(236) 
58 / 115 
(50%) 
GOS at 
6-months 
 
VBA 8 (7) 
85   
  
7 8
IV-V 19 (17)
85 7 8 16   /  8  2.6 / 3.5  
ICA 205 (22) I-II 558 (59) 91 4 5 
MCA 335 (35) III 290 (31) 68 13 19 
ACA 350 (37) 
Hernesniemi et al. -
93 (101, 189) 
(1007 patients 
including 60 
patients with UIA:s)
524 / 947 
(55%) 
GOS at 
12-months 
 
VBA 58 (6) 
78   
     
8 14
IV-V 99 (10) 30 23 47
24  /  14  
(at one year) 
6.9 / 3.9 
(In the whole series 
of 1007 patients 
with surgery) 
ICA 555 (27) 68 19 13 I-II 1057 (51) 86 9 5 
MCA 598 (29) 68 18 14 III 567 (28) 65 22 13 
ACA 777 (38) 69 19 12 
Osawa et al. -01 
(198) 
 
1685 / 2055 
(82%) 
GOS at 
discharge 
VBA 125 (6) 70 19 11 
IV-V     431 (21) 32 37 31
19  / 13  ? / 2.6  
 
Note: MCA = middle cerebral artery, ACA = anterior cerebral artery, anterior communicating artery, pericallosal artery 
ICA = internal carotid artery, ophthalmic artery, posterior communicating artery, anterior choroidal artery, VBA = vertebrobasilar arteries 
GOS = Glasgow Outcome Scale (124), GR = good recovery, MD = moderate recovery, SD = severe disability, VS = vegetative state 
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results and resulted in death or disability in 13.5% of the patients studied. Rebleeding 
was the second most prominent cause of mortality and mortality, producing 
unfavorable results in 7.5% of patients. 
The defined hospital populations of patients and aneurysms as well as the 
overall management outcomes in the retrospective study of Seiler et al. (238) and the 
prospective study of Säveland et al. (236) were in accordance with the populations 
and results of the Cooperative Study (135). Accordingly the surgical outcomes were 
clearly better than the overall outcomes. The results are summarized in Tables 2 and 
3. However, although the surgical results in the series of Säveland et al. (236) were 
in accordance with the other two studies, they could not be summarized in detail, 
thus those results have been omitted from Table 2. In this series the overall 
percentage of full recoveries was 56% versus 66% in surgically treated patients; with 
the corresponding mortality rates being 21% versus 11%.  
Delayed ischemia accounted for 13% of unfavorable outcomes in both the 
studies of Seiler et al. (238) and Säveland et al. (236), while in the Cooperative Study 
(135) DID caused 32% of the unfavorable outcomes. The difference may be 
explained by the fact that in contrast to the Cooperative Study (135) most of the 
patients received nimodipine in both of the first mentioned studies (236, 238). 
Rebleeding caused unfavorable outcomes in 9.8% of the patients in the study of 
Seiler et al. (238), in 7.5% of the patients in the Cooperative Study (135) and in 4.3% 
of patients in the study of Säveland et al. (236). Approximately half of the surgically 
treated patients in the Cooperative study (135) and in the study of Seiler et al. (238) 
underwent surgery within 3 days after SAH, while in the study of Säveland et al. 
(236) the corresponding proportion of patients was 72%.  
In the retrospective hospital based study of Hernesniemi et al. (101, 189), 55% 
of patients underwent early surgery. This series contains 1150 patients with 
intracranial aneurysms. Surgical cases, and patients with multiple bleedings and 
emergency surgery are included in the analysis. Morbidity (24%) and mortality (14%) 
rates are comparable with the rates in the Cooperative Study (135) (Table 3). 
Accordingly preoperative clinical grade (Hunt&Hess), age of the patient and size of 
the aneurysm were strongly related to outcome. The best results were obtained in 
the ACA aneurysms; the lowest rate of useful recoveries was achieved in the VBA 
aneurysms. The retrospective hospital based study of Osawa et al. (198) include 
surgical results of 2055 patients treated between 1988 and 1998, thus representing 
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modern standards of surgical and medical treatment of aneurysmal SAH. Eighty-two 
percent of patients were treated within 3 days of SAH. Mortality and morbidity rates 
are comparable with the aforementioned studies. The outcome of basilar artery 
aneurysms was significantly poorer compared to other sites including vertebral artery 
aneurysms. However, in this study the outcomes have been evaluated at discharge, 
which makes it difficult to compare these figures with the data from other series 
(Table 3). In the Hernesniemi study (101, 189), mortality increased by four percent 
between discharge from the hospital and the one-year follow-up.  
 
5.1.4. Special features and limitations of surgical treatment  
 
There are several instances where surgical treatment of acutely ruptured aneurysms 
is either challenging or even impossible. Recent prospective series reported a 
frequency of 30% of intraoperative complications resulting in poor outcome in 7.9% 
of the patients (74). Swelling of the brain accounted for 29% of all intraoperative 
problems, although a swollen and tight brain did not appear to be a serious practical 
problem in another series (136). However, patients with severe bleedings and poor 
clinical grades have not usually been considered as good candidates for early 
surgical treatment (101, 238). In particular, giant aneurysms and posterior circulation 
aneurysms that pose anatomic difficulties may be too hazardous to be surgically 
treated during the early phase after SAH (100, 152, 203). On the other hand, it may 
be possible to differentiate those poor grade patients and patients with posterior 
circulation aneurysms in whom the early surgical intervention is feasible (11, 105, 
152, 203).  
Perioperative rupture of the aneurysm has been reported to occur in 6% to 21% 
of cases (13, 55, 74, 101, 113). This event may occur during clipping, aneurysm 
dissection, brain retraction, hematoma evacuation or even more prematurely, 
immediately after the dural or arachnoid opening (13, 55, 101, 113). Very premature 
rupture tends to be a catastrophic event with a high mortality (113). Presumably the 
dissection technique and the surgeons experience are factors that influence the 
incidence of premature rupture and its outcome. A premature rupture may be 
handled by using suction, cottonoid tamponation and temporary ligation of the 
proximal parent artery (55, 289). In the posterior circulation aneurysms, a premature 
rupture may double the morbidity and mortality even in the most experienced hands 
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(55). In the series of Batjer et al. (13), 88% of the patients with uneventful operative 
procedures had favorable outcomes, whereas only 62% of the patients suffering 
intraoperative rupture recovered well. However, in anterior circulation aneurysms, 
perioperative rupture may not have any major influence on outcome, but temporary 
ligation or inadvertent ligation of a main vessel during the acute stage of SAH may 
often be catastrophic (101).  
A special group of patients are those with multiple aneurysms. Many aneurysms 
may be approached at one session, but certain contralateral aneurysms and 
aneurysms in other unreachable locations may necessitate a second-stage 
operation. Ligating many aneurysms inevitably leads to increased manipulation of the 
brain and the adjacent arteries, thus potentially adversely affecting the outcome 
(224).  
 
Incidence and natural history of surgical aneurysm remnants 
It is generally considered that incomplete clipping of the aneurysms rarely occurs. 
Feuerberg (63) reported 3.8% of aneurysm remnants in a series of 715 patients with 
routine immediate follow-up angiography. Of the 147 clipped aneurysms, 8.2% 
displayed a residual neck on immediate postoperative angiography in the study of 
David et al. (39). Tsutsumi et al. (262) studied 454 clipped aneurysms 
postoperatively and reported aneurysm remnants in 7.3% of those cases. Sindou et 
al. (242) reported 5.9% of incompletely clipped aneurysms in a series of 305 
operated patients. A recent systematic review of the literature summarized the overall 
incidence of 5.2% of incompletely clipped aneurysms (256). 
There are few data on the long-term angiographic follow-up of surgically treated 
aneurysms. Even those aneurysms with perfect clip position on immediate control 
have been reported to regrow in 1.5% to 2.4% of cases (39, 262). The clip may slip 
from the aneurysm neck or growth may occur apparently from a tiny bit of the neck 
that has remained unobserved after clipping (160). Regrowth from an aneurysm 
remnant has been reported in 5% to 25% of cases (39, 63, 262), and in broad-based 
residual necks, the frequency may be significantly higher (75%) (39). On the other 
hand, spontaneous thrombosis or a decrease of the remnant may occur in up to 35% 
of the cases (63). The risk of hemorrhage of an aneurysm remnants may be 0.4% to 
1.9% / year (39, 55, 63). Tsutsumi et al. (263) calculated a 9.0% cumulative 
recurrence rate at 20 years after SAH. In their series, 2 of 6 rebleedings were from 
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de novo aneurysms, which had not been visible in the original angiography. With 
respect to these data long-term angiographic follow-up is suggested for those 
patients with aneurysms with known residual necks, and for young patients even 
when there has been complete clipping of the aneurysm (39, 160, 262).  
 
5.1.5. Improvement of surgical treatment 
 
There are constant improvements in the performance of operating microscopes, 
more and more sophisticated clips and surgical micro instruments. Several diagnostic 
and therapeutic advances in the management of SAH have emerged during the last 
decades. There is no direct evidence that the improvement in surgical technique has 
actually improved the outcome of patients. However, there is no doubt that profound 
experience in microsurgery gives better results. Improvements in neuroanesthesia, 
critical-care techniques and the management of VSP in addition to a policy of earlier 
treatment may be associated with the improved outcome observed during the last 
decades (49, 72, 106, 149). 
 
5.2. Endovascular treatment of ruptured intracranial aneurysms 
 
Several endovascular treatment techniques for intracranial aneurysms have been 
developed over the past 20 years. These techniques were initially intended for use in 
those patients with aneurysms that were considered unclipable or in patients with a 
high risk for morbidity and/or mortality. In 1974 Serbinenko (239) published results of 
endovascular balloon occlusion of the carotid artery for treatment of unclipable 
aneurysms. Subsequently, silicon and detachable balloons were used to induce 
aneurysm thrombosis by occlusion of the parent vessel (43) and by trapping the 
aneurysm with two balloons (16). In 1982 Romodanov and Scheglov (227) reported a 
series of 93 patients who had their intracranial aneurysms completely occluded using 
a detachable balloon catheter without compromise of the parent vessel. In several 
subsequent reports, detachable balloons were advocated to pack the aneurysm sac 
allowing the preservation of the parent vessel (102-104). However, the rate of 
morbidity and mortality in these series was high.  
In 1990 Graves et al. (78) reported the treatment with platinum coils of 21 
experimental aneurysms of the lateral wall of the carotid artery. Thrombogenic coils 
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augmented with silk fibers resulted in total thrombosis of the aneurysm in only 40% of 
the treated aneurysms. Dowd et al. (51) were among the first to introduce platinum 
coils into intracranial aneurysms. These “free coils” were pushed through the 
microcatheter with a separate delivery wire. The problem with these coils was that 
they were impossible to control during deposition.  
 
5.2.1. The Guglielmi Detachable Coil system 
 
In 1991 Guglielmi et al. (88, 90) introduced an electrically detachable coil system 
(GDC) that permitted readjustment of the coil position before its final detachment. 
The GDC system consists of a platinum coil attached to a stainless steel delivery wire 
(pusher). The pusher has been coated for electrical isolation with the exception of the 
most distal part: the detachment zone. A guiding catheter is used in advancing to the 
ICA or vertebral artery. A microcatheter with 2-tip-markers and a guidewire are used 
for hyperselective catheterization of the aneurysmal sac. The distal end of the 
microcatheter is shaped with steam to tailor the vascular geometry before 
catheterization. Digital road mapping may be used in order not to touch the 
aneurysmal wall with the guidewire or catheter. A continuous pressurized flush of 
heparinized saline is maintained in both the guiding catheter and the microcatheter. 
The aneurysm sac is then filled with coils of selected shapes and sizes. The system 
allows the removal of the coil as well as repositioning of the mesh to an optimal 
position. When the coil is seen to be in a suitable position inside the aneurysm, 
positive direct electric current is applied to the proximal end of the stainless steel 
guidewire. The current provokes thrombus formation in the aneurysmal cavity and 
dissolves the uninsulated stainless steel coil closest to the platinum coil resulting in 
detachment of the coil (87, 90). Recently, several other detachable platinum coils 
have been developed.  
 
5.2.2. Clinical trials on endovascular treatment of ruptured aneurysms 
 
Most of the reports of patients treated by coil embolization for ruptured intracranial 
aneurysms have dealt with the short-term efficacy and procedural safety. In 
comparison with the recent large surgical series (96, 101, 135, 136, 198, 236, 238) 
most endovascular series (24, 27, 145, 216, 285) present with a considerable bias 
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concerning the nature of the population characteristics and the timing of the 
treatment after SAH. Due to the heterogeneity of the populations treated with coils 
comparison of the results is difficult. A summary of the results of the pivotal 
endovascular series is presented in Table 4. 
The largest study to date for the GDC embolization of recently ruptured 
aneurysms is the United States Food and Drug Administration-approved study (285) 
consisting of 403 patients. Posterior circulation aneurysms as well as large and giant 
aneurysms were over-represented. All aneurysms were treated within 15 days of 
rupture and 37% of the aneurysms within 48 hours of rupture. Complete aneurysm 
occlusion was detected in 70.8% of small aneurysms with a small neck, 35% of large 
aneurysms, and 50% of giant aneurysms. Overall rates of 8.9% morbidity and 6.2% 
mortality were observed. The mortality related to the GDC technique was 1.7%. Most 
patients had at least a 6-month clinical follow-up though this report does not present 
any systemic follow-up data (Table 4). The study of Malish et al. (167) seems to 
contain partially overlapping data with the above study and examined the midterm 
(Range for period from 2 to 6 years) clinical follow-up results of 48 patients 
presenting with SAH (Hunt&Hess grade I-II, 67%; III, 15%; IV-V, 19%). With respect 
to those patients with H&H grade I-II, 91% experienced an excellent or good recovery 
and 9% had a fair or poor recovery. Of patients of H&H grade III, 86% had an 
excellent or good recovery and 14% had a fair recovery. However, for patients with 
grade IV-V only 22% had fair or poor recovery and 78% died. Sixty-six percent of the 
ruptured aneurysms were located in the posterior circulation and the vast majority of 
the patients were considered very poor candidates for surgery. Only 17% of the 
patients with SAH were treated within 3 days after the hemorrhage. 
Raymond and Roy presented (216) a series of 75 patients with acutely ruptured 
aneurysms treated with GDCs. The 6-month angiographic follow-up data was 
available for 50 (67%) patients of whom 88% had complete or nearly complete 
occlusion of their aneurysms. Eighty-two percent of patients with Hunt&Hess grades 
I-III had good 6-month clinical outcomes with procedure related morbidity and 
mortality of 8% (Table 4).  
The recent series of Cognard et al. (34) consisted of 150 patients with SAH 
(Hunt&Hess grade 0, 9%; I-II, 78%; III, 9%; IV-V, 21%). Altogether 132 of 150 
ruptured aneurysms were successfully treated. Clinical follow-up data for at least a 3-
month period was available for 120 patients. Excellent outcome and moderate 
 
 
Table 4. Summarized results of the pivotal clinical series of endovascular treatment of patients with acutely ruptured intracranial aneurysms. 
 
Overall / 
Procedure Related Study 
Number of  Patients with 
SAH / 
Average Follow-up Time 
 
Site of the 
ruptured 
Aneurysm 
(%) 
Hunt & 
Hess 
Grades (%) 
Outcome 
(GOS / Other Outcome 
Data) 
(%) 
Overall initial Complete 
Occlusion Grade or 
Occlusion Grade 
According to 
Aneurysm Size (%) 
Overall Final Occlusion 
Grade / Stability Of The 
Aneurysm Follow-up 
(%) Morbidity (%) Mortality (%) 
ICA 25 I-II 69 Good / Moderate 89 < 10 mm   (n=31) 94 Complete 83 
MCA 6 III 18 SD / Vegetative 0 11-25 mm (n=23) 82 Near complete 12 
4.2  11.3
ACA  10
Casasco et al. –93 
(27) 67 
GOS at 
6-months 
Angiography at 13-
months 
(65/71 pts) VBA  59
IV-V 13 Death 11 > 25 mm   (n=6) 60 Incomplete 5 
4.2 
rebleeding rate: 
2 / 67 = 2.8% 
7.0 
 
ICA           27 I-II 46 “Unchanged” 85 < 10 mm   (n=168) with neck ≤ 4 mm 71 Complete NA NA 6.2
MCA         3 III 30 “Deterioration” 9 < 10 mm   (n=77) with neck >4 mm 31 Near complete NA
ACA    13 11-25 mm (n=140) 35
Vinuela et al. -97 
(285) 403 
GOS at 
discharge 
Immediate 
angiographic 
results presented 
VBA        57 IV-V 24 Death 6 > 25 mm   (n=18) 50 Incomplete NA
8.9 
rebleeding rate: 
9 / 403 = 2.2% 
(≈ 6-36 mo f-up) 
1.7 
 
ICA 26 I-II 41 Good / Moderate 72 Complete 40 Complete 46 10.6 23.0 
MCA 9 III 40 SD / Vegetative 5 Near complete 37 Near complete 42 
ACA  17
Raymond and Roy 
-97 (216) 75 
GOS and 
*angiography at 
6-months 
* 50/75 patients VBA          48 IV-V 19 Death 23 Incomplete 19 Incomplete 12
4.0 
rebleeding rate: 
4/75 = 5.0% 
4.0 
ICA 36 I-II 52 Good / Moderate 74 Complete 41 Complete 41 NA 6.5 in SAH patients 
MCA 4 III 16 SD / Vegetative 19 Near complete 50 Near complete 46 7.8 (whole series) 
ACA  13
Kuether et al. -98 
(145) 
 
31 
GOS 2.2 years 
*Angiography 
1.5 years, 
combined data 
(ruptured and 
unruptured) VBA          47 IV-V 32 Death 7 Incomplete 9 Incomplete 13
9.1 
rebleeding rate: 
2.9% 
( whole series) 
6.4 (2/31 of the 
pts with SAH) 
ICA 22 I-II 76 Good / Moderate 81 < 10 mm   (n=176) 66 Stable 85.3 
MCA 16 III 13 SD / Vegetative 14 11-25 mm (n=81) 58 Recurrence 14.7 
ACA  26
Byrne et al. -99 
(24) 317 
6 Month GOS from 
98.7% of patients 
VBA  35 IV-V 11 Death 5 > 25 mm   (n=2) 50 
Improved  
occlusion grade 8.5 (?) 
NA 
5 / 259 pts had 
rebleeding (1.9%) 
 
NA 
ICA 22 Good / Moderate 89 Complete 52 Complete NA 7.5 10.9 
MCA  
  
2
I-III 80
SD / Vegetative 3 Near complete 32 Near complete NA 
ACA  18
Brilstra et al. -99 
(20) 
Meta-analysis of 
series reported 
before 1999 
509 
509 aneurysms in 
509 patients 
Outcome data from 
min. 436 pts VBA          58 IV-V 20 Death 8 Incomplete 6 Incomplete NA
1.1 
rebleeding rate: 
16 / 509 (?) 
= 3.1% / years? 
2.4 
 
Note: NA = Not available  
MCA = middle cerebral artery, ACA = anterior cerebral artery, anterior communicating artery, pericallosal artery 
ICA = internal carotid artery, ophthalmic artery, posterior communicating artery, anterior choroidal artery, VBA = vertebrobasilar arteries 
GOS = Glasgow Outcome Scale (122) 
GR = good recovery, MD = moderate recovery, SD = severe disability, VS = vegetative state
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disability of the patients was seen in 81% and 7% of patients respectively. Fifteen 
(11%) of the 132 patients died, technique-related mortality was 3%. Immediate total 
occlusion rate was 79% of all aneurysms.  
Debrun et al. (44) presented their series of 144 patients of whom 55 patients 
with ruptured aneurysms and 89 patients with unruptured ones. For the patients with 
SAH (Hunt&Hess grade I, 24%; II, 29%; III, 25%; IV, 14% and V, 7%), an excellent 
outcome was seen in 74%, with procedure-related morbidity and mortality of 3.6% 
and 1.8% respectively. The data is presented differentiated into two groups 
representing the early and late experience in their series. 
Kuether et al. (145) examined clinical and angiographic outcomes from 74 
patients with aneurysms of whom 31 presented with SAH. At least a six-month 
clinical follow-up was available for all patients with SAH. Of the patients of H&H 
grade I-II, 81% wereindependent, 6% were moderately disabled and 13% died (2 
procedure related deaths). All the patients of grade III showed a good clinical 
outcome. Half of the patients with Grade IV-V recovered to independent status, 30% 
were left severely disabled and 20% died. Taking into account the unruptured 
patients, they observed 9.1% morbidity and 7.8% mortality rates related to GDC 
embolization (Table 4). 
Byrne et al. (24) reported their five-year experience of coil treatment for 
ruptured aneurysms in 317 patients. The median clinical follow-up time was 22.3 
months, which was available for 98.7% of patients. Excellent or good outcomes 
measured at 6 months post treatment were achieved in 87.8% of patients with WFNS 
grades I and II, in 71.4% of patients with WFNS grade III and in 48.5% of patients 
with WFNS Grade IV and V. Angiographic assessment of the degree of occlusion 
was made in 259 aneurysms in 250 (84.2%) of the available 297 patients between 6 
and 12 months after coil embolization. Following the treatment, 64% of the 
aneurysms were completely occluded, 34% had small remnants and 5% had more 
substantial residual filling. In all, 85.3% of the followed-up aneurysms remained 
stable or demonstrated an improved degree of occlusion, 14.7% of the aneurysms 
were enlarged to some degree (Table 4). 
In 1999 a systematic review included an analysis of all available studies of 
aneurysms treated by embolization with coils (20). Five hundred and nine patients in 
14 studies had ruptured intracranial aneurysms. The sites of the aneurysms were 
available from all patients, the clinical grades only from 488 patients and the time 
 
 
 42
interval between embolization and SAH from 436 patients. Aneurysm occlusion 
grades were available from all 509 patients but clinical follow-up data only from 93 
patients (Table 4). The deviation from normal population characteristics of the 
ruptured aneurysms is clearly demonstrated by the inability of the study to find any 
relation between outcome measures and aneurysm size, the aneurysm being 
ruptured or unruptured or any baseline characteristics. Although the severity of the 
initial bleeding has been consistently shown to be the most important predictive 
factor for late complications and outcome (135, 189), in this review no such relation 
could be found (20). 
 
5.2.3. Special features and limitations of Guglielmi Detachable Coil treatment 
 
Size, location and morphology of the aneurysms 
Factors that reportedly affect the success rate in endovascular coil occlusion include 
the luminal size, neck size, geometry and location of the aneurysm. Endovascular 
coil occlusion seems to be particularly feasible in small aneurysms. In two recent 
clinical series, more than 90% of small aneurysms and approximately 80% of large 
aneurysms could be sufficiently occluded (22, 285). However, the total occlusion rate 
achieved in giant aneurysms was only 50%. Zubillaga et al. (62) chose 4 mm as the 
discriminative value for wide versus narrow necks. They achieved a success rate of 
85% for narrow-necked aneurysm versus 16% for wide-necked aneurysms. Others 
have also emphasized the importance of neck-size (108). Debrun et al. (44, 45) 
emphasized the importance of aneurysm geometry, including shape and dome-to-
neck ratio, which should be at least 2 if one is to achieve a successful occlusion. 
They also suggest that the percentage of complete aneurysm occlusion is related to 
the density of coil packing.  
Giant aneurysms with wide necks remain a major therapeutic challenge. With 
respect to the currently available data, GDC treatment should be reserved for those 
individuals who are considered poor candidates for open surgery (82). 
The location of the aneurysm may not have any major effect on the achieved 
occlusion rate. However, vessel tortuosity and difficult anatomic positions may limit 
access to the aneurysm (23, 44). Configurations unfavorable to successful coiling 
include locations where multiple branches arise, such as the MCA trifurcation. A 
branch of a vessel may arise from the neck of the aneurysm, an anatomical 
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consideration often prevalent in posterior communicating artery (PCoA) aneurysms 
(44). The three-dimensional configuration of the aneurysm neck may be difficult to 
angiographically define especially in the anterior communicating artery (ACoA) 
aneurysms. However, some authors have reported that good and stable occlusion 
rates can be achieved by coil occlusion in this location as well (35, 181). Coiling more 
distal aneurysms requires meticulous coiling technique (176). 
Posterior circulation aneurysms, especially distal basilar artery aneurysms are 
the easiest to reach from the endovascular route, thus a high success rate with a low 
morbidity and mortality in ruptured aneurysms has been reported (60, 89, 157, 217). 
The feasibility of coil treatment for the posterior circulation aneurysms has been well 
demonstrated in patients with poor clinical grades (144). The ICA aneurysms located 
in close proximity to the skull base are also considered to be good candidates for 
endovascular coil treatment (92, 234).  
 
Thromboembolic complications 
In a recent review of 23 studies using GDCs for treatment of intracranial aneurysms, 
an overall rate of 8.2% of thromboembolic complications was assessed being related 
to GDC treatment of aneurysms (208). The majority of events occurred 
intraoperatively. The complications were asymptomatic or transient ischemic attacks 
(TIAs) in 33% of patients; rest of the patients experienced strokes with a mortality 
rate of 14%. In the above large clinical series, the reported rate of thromboembolic 
complications varied between 6.0% and 14.7% (27, 34, 44, 145, 216, 285).  
There are several different immediate versus delayed mechanisms that may 
predispose to thromboembolic events: 1) occlusion and manipulation of the parent 
vessel cause stasis of distal flow, which leads to intraluminal thrombosis; 2) during 
embolization of the aneurysmal sac with GDCs, emboli may be sheared off leading to 
parent artery occlusion; 3) the thrombogenic coil may slip or protrude into the vessel 
lumen and promote thrombus formation; 4) if the occlusion is incomplete, a new 
thrombus may form in an aneurysm remnant (208, 209).  
For patients with SAH, perioperative heparin administration is recommended. A 
routine postprocedural use of heparin is not recommended because of the risk of 
rebleeding (271). However, there are exceptions e.g. the patients with a coil 
protruding in the parent vessel, with angiographically evident thrombus outside the 
aneurysm, or with procedure related ischemic symptoms. Those patients may benefit 
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from heparin administration to be continued for 24 hours postprocedurally. A 
combination of aspirin and ticlopidine may be used for 4 weeks, to ensure 
endothelialization of thrombogenic surfaces. The risk of thromboembolic events 
should be very low after the first 4 weeks (208, 209). 
 
Rupture during treatment of acutely ruptured aneurysms 
Aneurysm perforation may occur during catheterization or placement of coils into the 
aneurysm. Several recent reports highlight this complication (173, 221, 243, 265). 
Recently ruptured aneurysms carry a higher risk for rupture than unruptured 
aneurysms (187, 221, 265). Furthermore, a small aneurysm size has been proposed 
to predispose towards rupture (221, 243), but the likelihood of perforation may be 
more dependent on the coiling technique used than any factor related to the 
aneurysm itself (265). The rate of perforations reported in the literature varies 
between 0.8% and 8.0% (265). In the largest GDC series of 403 patients, the rate of 
perforations was 2.7%, this being fatal in 6 of the 11 patients who experienced 
perforation (285). According to a recent review (243) of 13 studies in which the 
results of 2030 aneurysm treatments were reported, procedure-related rupture of 
intracranial aneurysms during GDC treatment occurs in 2.5% of cases and is 
responsible for 1% of treatment-related deaths. 
The suggested treatment in the case of aneurysm rupture during coiling is to 
reverse anticoagulation therapy and rapidly continue GDC coil delivery until complete 
occlusion is achieved (173, 221, 265, 285). However, the patient may rapidly 
deteriorate due to the elevation of intracranial pressure. Therefore, neurosurgical 
assistance should be available for all embolization procedures and emergency 
craniotomy or ventriculostomy may be indicated after an intraprocedural aneurysm 
rupture (221, 265). 
 
Remnants of aneurysms after treatment with Guglielmi Detachable Coils 
Long-term stability of GDCs is a potential concern. The orifice of the aneurysm may 
remain open since failure to achieve endothelial proliferation to cover the luminal 
surface of the thrombus has been found in animal studies (219) and in histological 
follow-up studies of previously coil treated aneurysms (14). The late occurrence of 
coil movement and compaction may predispose aneurysm revascularization or 
growth. Even those aneurysms with initial total occlusion after coil embolization have 
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shown a rate of 1.8% to 37% of refilling (24, 35, 44, 145, 187, 257). Furthermore, the 
long-term natural history of the neck remnants remain largely unknown. 
Completeness of obliteration may spontaneously improve in 8.5% to 46% of coiled 
aneurysms (24, 44, 98, 187, 257). In two recent follow-up series, however, 
recanalization of the incompletely occluded aneurysm occurred in 28% to 46% of 
cases (98, 257). Thus, occlusion of the coiled aneurysms may frequently be 
unstable.  
In their 5-year follow-up study consisting 317 patients, Byrne et al. (24) 
calculated overall annual rebleeding rates of 0.8% in the first year, 0,6% in the 
second year, and 2,4% in the third year. No further rebleedings occurred in the 67 
patients who were observed beyond 3 years. They did not detect any difference in 
the stability between the small or large aneurysms. Large and giant aneurysms have 
found to have a substantially higher risk of rebleeding (4 and 33%, respectively) 
(167). Raymond et al. (216) observed subsequent rebleeding in 4 of 75 patients after 
treatment of acutely ruptured aneurysms, 75% of rebleedings occurred in aneurysms 
that were initially incompletely occluded. 
The efficacy of the GDC treatment is an essential issue. Postembolization 
angiography is usually recommended for all treated patients within a 6-month post 
treatment period (24, 35, 44, 98, 145, 216, 285). Recommendation for follow-up 
thereafter varies from a single 1-year angiography (285) to annual angiographies for 
all coiled aneurysm (216).  
 
5.2.4. Improvement of endovascular techniques 
 
The latest current technological solutions to treat those aneurysms with wide necks 
and to prevent recanalization include a new generation 3 D coils (32), neck-bridge 
devices (214), the remodeling technique of balloon assisted GDC placement (6, 156, 
166, 180), and a new generation of flexible stents, which allow tight coil packing 
through the stent and may provide an endoluminal matrix for endothelial growth (148, 
177). Embolization of wide-necked aneurysms with new liquid embolic agents 
combined with protective devices, such as flexible stents or microballoons have 
proved feasible in experimental settings (185), as well as in clinical studies (170). 
Endovascular treatment by intra-aneurysmal injection of glue may be preferable to 
GDC embolization in aneurysms in very distal locations (36). 
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The further development of GDC coils includes development of the biologically 
active covered coils (2). In experimental studies, ion implantation and protein coating 
have been used in order to alter the surface properties (thrombogenicity, endothelial 
cellular migration, and adhesion) of GDCs (183). Experimental coils coated with new 
bioabsorbable polymeric materials (184), as well as radioactive platinum coils (32P-
coils) (215) may accelerate aneurysm fibrosis and intensify neck neointima formation. 
 
5.3. Combined endovascular and surgical treatment of ruptured aneurysms 
 
Previous incomplete endovascular treatment does not necessarily hinder subsequent 
successful surgery, provided the coils are compacted in the dome and do not 
protrude into the neck or into the parent vessel (30, 91, 258). Difficulties are 
encountered when the aneurysm is either small and incompletely occluded with coils 
or when the coils protrude into the lumen of the parent vessel (91, 258). Occasionally 
further treatment is considered necessary even though the coils remain in the basal 
portion of the aneurysm. In such cases, clip placement over the coil mesh or simple 
remodeling of the neck of the aneurysm with a clip allowing further treatment by coils 
may represent a good option for treatment (110). 
Sometimes incomplete surgical clipping may be safely accomplished by 
endovascular treatment with coils (255). Excellent results may be achieved when 
these two treatment methods are used in a complementary fashion. The 
endovascular approach is less dependent than surgery on the location of the 
aneurysm, the clinical state of the patient, and the timing of the intervention (285). 
 
5.4. Clinical trials comparing endovascular and surgical treatment of ruptured 
aneurysms 
 
The current literature contains no prospective or randomized series comparing 
endovascular and surgical treatment of ruptured aneurysms. The retrospective 
outcome studies consisting of consecutive patients of defined time period share the 
findings that GDC embolization does not seem to be associated with a higher risk of 
morbidity and mortality than open surgery (128, 153). Richling et al. (220) detected a 
slight tendency toward better early clinical outcome in a small subgroup of patients 
with Hunt&Hess Grade III who were treated with GDCs (220). The clinical outcomes 
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seemed comparable in the studies of Kähärä et al. (128) and Leber et al. (153). 
However, in all of these studies, the patient populations were imbalanced and the 
outcome results have been reported in insufficient details.  
Struraitis et al. (247) retrospectively investigated the impact of the introduction 
of the GDC therapeutic option on the overall management outcome of intracranial 
aneurysms. They could not find any significant impact of integration of the GDCs in 
the protocol of treatment on clinical outcome, mortality, morbidity, or effectiveness of 
treatment. Hadjivassiliou et al. (94) compared cognitive outcome as well as structural 
damage after aneurysmal SAH and treatment with either clips or coils. They 
suggested that endovascular treatment might cause less MRI detectable structural 
brain damage than surgery. Furthermore, endovascularly treated patients seemed to 
have a more favorable cognitive outcome based on comprehensive 
neuropsychological tests performed one year after treatment. 
Several studies focus on specific aspects related to the treatment of patients 
with SAH. Groden et al. (80) found similar outcomes in 40 poor grade patients 
(Hunt&Hess IV-V) with anterior circulation aneurysms treated either endovascularly 
(n=20) or surgically (n=20). Gruber et al. (86) compared patients with acutely 
ruptured basilar artery apex aneurysms and comparable Hunt&Hess grades of I-III 
treated either with clipping (n=13) or GDCs (n=11). The patients who underwent 
GDC embolization had significantly better outcomes and a shorter hospital stay than 
the surgically treated patients. The two studies investigating the frequency of chronic 
shunt-dependent hydrocephalus (83) or the frequency of interventions needed for 
treatment of hydrocephalus (240) could not find any differences between the results 
of the groups treated either with GDCs or clipping. Similarly no clear association with 
the frequency of VSP and the modality of treatment chosen could be shown (85). 
 
6. Splanchnic tissue perfusion in critically ill patients 
 
Medical complications after aneurysmal SAH may significantly contribute to the 
overall mortality rate (101, 135, 136, 149, 244, 293). The most often encountered 
medical complications include hypertension, sepsis or pneumonia, meningitis, 
venous thrombosis, pulmonary embolism, anemia, cardiac arrhythmias, 
gastrointestinal bleeding, inappropriate ADH secretion (SIADH syndrome) and wound 
infection (101, 135, 244). Extracerebral organ system failures (OSFs) and increased 
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mortality have been found to be associated with the occurrence of systemic 
inflammatory response syndrome (SIRS) without infection, which is encountered also 
in other types of cerebral injury (84, 293). Insufficient splanchnic tissue perfusion has 
been regarded as one of the possible mechanisms responsible for the SIRS and 
OSFs (7, 155).  
 
6.1. Assessment of splanchnic tissue perfusion 
 
Many invasive methods have been available to monitor gut perfusion. These include 
direct doppler investigations, reflectance spectrophotometry, transcutaneous oxygen 
measurements and measurement of hepatic venous oxygen saturation, lactate 
concentration and blood flow (201). However, these invasive methods are not used in 
clinical practice.   
Gastric tonometry is a noninvasive method which has been used to assess the 
adequacy of visceral tissue oxygenation (64). Measurement of intramucosal PCO2 
(PgCO2) with CO2gap (gastric-to-arterial CO2 difference) has been preferred to pHi. 
PgCO2 has been proposed to be a more specific index of gut mucosal perfusion than 
pHi (154).  
 
6.1.1. Gastric tonometry 
 
Gastric tonometry is a relatively noninvasive way to measure the mucosal pHi. The 
saline tonometric technique for assessing gut luminal PCO2 was first introduced in 
1982 (65). A gastric tonometer is a gas-impermeable sampling tube to which a gas-
permeable silicone balloon has been attached distally. After being placed in position, 
the balloon is filled with saline. Following an equilibration time of at least 10 min, the 
PCO2 of the saline becomes equilibrated with the PCO2 of the gastrointestinal 
lumen. A sample of saline can then be aspirated and PCO2 determined with a blood-
gas analyzer. Assuming that the bicarbonate (HCO3
-) concentration in the mucosa 
and in the arterial blood are equivalent, pHi can be calculated by applying a modified 
Henderson-Hasselbalch equation: pHi = 6.1 + log (arterial HCO3
- / α . tonometer 
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PCO2 . k), where α represents the solubility of CO2 in plasma (α = 0.03) and k is the 
time-dependent factor of equilibration (64). 
There are several problems associated with pHi measurements. The 
measurements of PCO2 from saline samples can introduce errors in pHi values 
because of the low stability of PCO2 in saline and the large variations in the quality of 
the many gas analyzers (222, 249). Due to the equilibration period needed, the data 
obtained is not real time data and thus rapid changes cannot be promptly detected 
(155). Recently these methodological drawbacks have been largely eliminated with 
the development of automated gas tonometry. This technique allows semi-
continuous monitoring of gut-to-end-tidal PCO2 difference (Pg-etCO2) where 
PetCO2 is used as a non-invasive index of arterial PCO2 (PaCO2) (37). 
 
6.1.2. Gastric tonometry, clinical experiences 
 
Gastric tonometry has been investigated as a diagnostic tool, as a predictive tool and 
as a therapeutic index (154). Several studies have shown that low pHi after 
admission to or during intensive care predicts an increase in morbidity and mortality 
in critical care patients (93, 200). Therefore, the rationale to diagnose and correct 
splanchnic tissue hypoperfusion is logical. However, the results of studies using 
“splanchnic-directed therapy” are controversial. In their prospective randomized 
series of 260 patients, Gutierrez et al. (93) concluded that therapy guided by pHi 
measurements improved survival in patients whose pHi on admission to ICU was 
normal but not in those patients whose pHi on admission was already low. However, 
Gomersall et al. (76), in their prospective randomized study of 210 patients failed to 
improve the ICU outcome by treating patients with pHi <7.35 with additional colloids 
and dobutamine. Equally, Pargger et al. (200) could not improve postoperative 
outcome in patients after elective repair of infrarenal abdominal aneurysms by 
treatment to elevate low pHi values. On the other hand, in the study of Barquist et al. 
(12), trauma patients having persistent low pHi (<7.25 mmHg) seemed to benefit 
from a “splanchnic-directed therapy”. Venkatesh et al. (279) investigated splanchnic 
ischemia in patients with brain injury, and found evidence that splanchnic ischemia 
occurs commonly in isolated neurotrauma, with a trend toward development of 
mucosal ischemia with decreased cerebral perfusion. There is a lack of clinical 
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studies using CO2gap determined with saline tonometry or Pg-etCO2 automated gas 
tonometry as the therapeutic tool (154). 
 
7. Cerebral vasospasm  
 
The most feared complication of SAH is a form of delayed-onset cerebral arterial 
narrowing known as VSP (66). Angiographic VSP is detected in 50% to 70% of 
patients in the first two weeks after SAH (276). In about one-half of cases, 
angiographic VSP manifests itself by the occurrence of a delayed ischemic 
neurological deficit, which may resolve or progress to permanent cerebral infarction 
(171). The development of delayed ischemic deficit (DID) is still considered to be the 
major cause of morbidity and mortality in the patients who survive long enough to 
reach the neurosurgical unit. In a recent large multicenter study, DID killed 7% of 
patients with aneurysmal SAH and left another 7% with severe permanent 
neurological deficits (135). Despite intensive research in the field of VSP and 
developments in the therapy, the figures at the present time have not changed to any 
significant extent (101, 171, 189, 274). 
 
7.1. Etiology and pathophysiology of delayed ischemic deficit 
 
The acute period of VSP is fully developed within 3-5 days after SAH and lasts for 2-
3 weeks (277). It is best characterized as prolonged intense vasoconstriction, which 
leads secondarily to smooth cell damage (68). When the arteries are constricted, 
endothelial cells lose their flat shape and a major increase in wall thickness occurs in 
the media (67, 274, 277). The time course for the development of DIDs follows the 
time course of the development of VSP. According to Weir et al. (276, 277) the most 
common time for the appearance of delayed ischemic neurological deficits is after 
day 4 following SAH, and they rarely appear later than day 14 after SAH. There is 
evidence that parenchymal vessels distal to arteries undergoing angiographic spasm 
after SAH do not show normal autoregulatory vasodilatation (294).  
Blood localized in the subarachnoid space has been considered to be the most 
important etiological factor in VSP (68, 70, 139). Probably compounds released from 
the clot interact in some way with the vessel wall. The time course of the spasm 
could be explained by some spasmogen released from erythrocytes during their 
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hemolysis in CSF (67). Although VSP probably has a complex and multifactorial 
pathogenesis, hemoglobin, particularly oxyhemoglobin, seems to be an important 
cause of VSP. Other substances, which have been considered as possible causes of 
VSP, include: methemoglobin, bilirubin, eicosanoids, serotonin, epinephrine and 
neuropeptides (67, 274).  
Classically, the clinical symptoms of VSP consist of impairment of 
consciousness, confusion, disorientation, and worsening neurological deficits such as 
dysphasia and hemiplegia (277). The clinical diagnosis of VSP is traditionally based 
on the time of onset of the deficits, the rate of development of the deficits (hours), the 
nature of the deficits and the exclusion of other factors that may cause gradual 
deterioration of the patient or focal neurological signs (133). The diagnosis is 
therefore not always definitive. It is especially difficult to differentiate symptoms of 
VSP from other causes that worsen the clinical state in patients with impaired 
consciousness (48, 144).  
 
7.2. Diagnostic methods of investigating vasospasm 
 
Invasive digital subtraction angiography is still the standard method for assessing the 
degree of arterial narrowing caused by cerebral VSP (70). However, this technique is 
invasive and carries a risk for complications (31). That has encouraged the search for 
less invasive methods for evaluating the degree of arterial narrowing. CTA has been 
found to be highly accurate in detecting either no spasm or severe VSP in proximal 
arterial location, as compared with DSA (8). A study of 0.5 T MR angiography with 
3D-TOF MRA in diagnosing VSP after SAH showed excellent sensitivity for detecting 
VSP for the ACA (100%), moderate for the MCA (56%) and poor for the ICA (25%) 
(77). Many studies have demonstrated that after SAH there is a fall in cerebral blood 
flow to a degree which depends on the severity of VSP (120, 288).  
 
7.2.1. Assessment of regional cerebral blood flow  
 
Regional CBF after SAH depends on dynamic pathophysiological processes and it 
would ideally be continuously monitored for several days. There is, however, lack of 
bedside methods allowing continuous monitoring of rCBF readily introducable for 
clinical use. Indirect bedside estimation of CBF is possible by investigating cerebral 
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blood flow velocities with transcranial doppler ultrasound (TCD) using simultaneous 
cerebral perfusion pressure data (1). However, there are no semiquantitative nor truly 
quantitative methods currently available for investigating rCBF which are suitable for 
bedside monitoring.  
 
7.2.2. Positron emission tomography  
 
Positron emission tomography (PET) is the gold standard for quantitative evaluation 
of rCBF. Additionally this method allows quantitative measurement of regional 
cerebral blood volume (rCVB), regional cerebral oxygen utilization (rCMRO2) and 
regional oxygen extraction fraction (rOEF) (206, 294). The PET radiopharmaceuticals 
for brain imaging that are labeled with positron-emitters have to be first prepared in a 
cyclotron, which is the major limiting factor preventing their routine clinical use. 
However, there are several clinical PET-studies evaluating rCBF and brain 
metabolism in the acute stage of SAH (81, 99, 206, 294).  
 
7.2.3. Radioactive and stable xenon methods 
 
Both the 133Xe injection method (118) and the 133Xe inhalation method (178) have 
been used in quantitative evaluation of changes in rCBF after SAH as well as in 
evaluating the correlation of those changes with symptomatic VSP and patient 
outcomes. The main advantages of the more recently introduced Xenon-Computed 
Tomography (XeCT) is that it noninvasively provides rapid access to high-resolution, 
quantitative, local CBF information coupled to CT anatomy. The technology can be 
incorporated into all existing CT technology at relatively little expense. Since flow 
measurements based on Xe can be repeated within 20-minute intervals, flow 
measurements before and after the “therapeutic” manipulation of blood pressure 
have proven useful for guiding therapy after SAH. The disadvantages are the 
radiation dose from the CT scanner, the pharmacological effects of xenon gas, and 
the limitations of the survey (123, 292).  
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7.2.4. Single photon emission computed tomography  
 
Nuclear imaging of the brain with the SPECT technique uses radionuclides emitting 
gamma radiation. Brain perfusion imaging requires radiotracers, which efficiently 
cross the blood-brain barrier so that uptake is proportional to cerebral blood flow 
(146). SPECT images are generated using gamma cameras that record photons 
emitted by tracers trapped in the brain. Data collection with a modern multihead 
gamma camera provides a good spatial resolution and image quality (46, 169). Of 
the many radiotracers available for imaging CBF with SPECT, d,l-
hexamethylpropyleneamine oxime (99mTc-HMPAO) is the most widely used. The 
more recently introduced technetium-labeled tracer ethyl cysteinate dimer (99mTc-
ECD) is considered to fit CBF more closely than 99m Tc-HMPAO (9). 
Brain perfusion SPECT does not routinely allow quantitation of rCBF. Absolute 
quantification of perfusion by means of single-photon emission tomography (SPET), 
most often requires arterial sampling, careful modeling and highly accurate 
instrumentation (169, 270). However, the spectral analysis technique may allow non-
invasive absolute quantification of CBF by means of 99mTc-ECD, which has direct 
applicability in routine settings (270). 
For a number of routine clinical studies, qualitative or semi-quantitative images 
of brain perfusion are sufficient. Initial visual analysis helps in selecting certain 
regions of interest (ROIs) for further evaluation of disturbances in rCBF (9, 40, 41, 
159, 259). In semi-quantitative analysis of CBF, the counts of tracer uptake in some 
internal reference point has to be used for comparison to the regional counts of tracer 
uptake in the desired ROIs. Either cortico-cerebellar ratios or lesion-to-contralateral-
normal ratios may be used (40, 41, 146, 159). Although, semiquantitative estimation 
of rCBF improves the accuracy of SPECT evaluation, the results are commonly 
reported on the basis of visual interpretation only (207, 211, 232). In clinical use, 
qualitative SPECT imaging with rCBF markers has provided useful data for detecting 
VSP (40, 207, 245).  
 
7.2.7. Diffusion and perfusion weighted magnetic resonance imaging 
 
The new MR imaging techniques of perfusion and diffusion imaging are exquisitely 
sensitive in revealing early infarction in cases of ischemic stroke (79). 
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Different patterns of flow alterations depending on the time of MR imaging after SAH 
has been detected using MRI perfusion and diffusion imaging techniques, findings 
consistent with the known pathophysiology of VSP (79, 231). MR imaging may be an 
ideal technique for the evaluation of VSP since it can address both the angiographic 
findings for direct identification of arterial VSP and the functional aspect by measuring 
the regional CBF and CBV (77). 
 
7.2.8. Transcranial doppler ultrasound  
 
The use of an ultrasonic TCD technique has been proposed for noninvasive 
evaluation of cerebral VSP (1). Although, TCD velocity changes have been found to 
be useful in diagnosing and managing elevated cerebral blood flow velocities (CBFV) 
and ischemic neurological deficit following SAH (273), in many studies the limitations 
of TCD evaluation alone have been highlighted. Even if the presence of proximal 
arterial narrowing is correctly identified, TCD does not directly address the more 
important question of the effects of this VSP on the rCBF in the associated vascular 
territories (33, 41, 69). Vora et al. (287) found out that for individual patients, only low 
or very high MCA flow velocities (i.e., <120 or > or =200 cm/s) reliably predicted the 
absence or presence of clinically significant angiographic VSP. Comparison studies 
of TCD and CBF examination have shown that the most common pathological finding 
associated with elevated blood flow velocities is hyperemia instead of ischemia (33). 
By demonstrating a loss of autoregulation, a vascular territory that is acutely ischemic 
can be identified more reliably. Transient hyperemic response test (THRT) in 
conjunction with TCD evaluation for examining the autoregulatory reserve has been 
found to predict the development of DIDs after aneurysm treatment with a high 
degree of accuracy (147, 213). 
 
7.3. Treatment of cerebral vasospasm 
 
Treatment strategies can be divided into those directed at preventing or reversing 
arterial narrowing, those directed primarily at preventing or reversing the resulting 
cerebral ischemia and protecting from infarction (133).  
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7.3.1. Preventing or reversing arterial narrowing 
 
Early surgery was introduced after it was considered that early clipping of the 
aneurysm not only prevented rebleeding but also allowed surgical removal of 
spasmogenic clot form the basal cisterns (250). The concept of intrathecal fibrinolytic 
treatment after SAH is to promote rapid dissolution of blood clot prior to hemolysis 
and the release of spasmogenic intermediates. A trend toward less severe VSP and 
improved outcome with fibrinolytic treatment was seen in two recent prospective, 
randomized studies (67, 196). A recent review of literature found similar tendency 
toward decreased occurrence of severe VSP with rt-PA (260). 
Initially, the use of calcium channel blockers in the prevention or treatment of 
secondary ischemia was based on the assumption that these drugs reduce the 
frequency of VSP by blocking influx of the extracellular calcium needed for 
contraction of large cerebral arteries. However, subsequent studies have 
demonstrated that nimodipine does not significantly prevent or reverse large-vessel 
narrowing after SAH (67). A recent systemical review of all randomized controlled 
trials on calcium antagonists in patients with SAH showed a significant reduction of 
secondary ischemia and, thus in the frequency of poor outcome (61). Separate 
analysis showed that only nimodipine had a positive effect on outcome; nicardipine 
and AT877 significantly reduced the frequency of VSP. Thus calcium antagonists 
maybe should be classified as neuroprotective agents. In addition, their use may 
favor the development of collateral circulation (260). 
Recent development in endovascular treatments have enabled the direct 
dilatation of constricted cerebral arteries by transluminal angioplasty (151, 296). 
Since angioplasty is not effective in dilating the distal arteries, superselective intra-
arterial papaverine administration was proposed as an alternative or conjunctive 
method of treatment (131). Subsequently the use of intra-arterial papaverine has 
been discouraged (205), and the studies comparing the effects of transluminal 
angioplasty with intra-arterial papaverine have found angioplasty to be superior in 
reversing DID and in improving CBF (58, 69).  
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7.3.2 Preventing or reversing delayed ischemic deficits and protection from infarction 
 
Induced hypertension combined with volume expansion was found to be effective in 
reversing ischemic symptoms caused by cerebral VSP already in the 70’s (143). The 
hypertensive component of this therapy was based on the hypothesis that in the 
presence of impaired autoregulation cerebral blood flow is directly dependent on 
perfusion pressure (10, 118, 143). The rationale for hypervolemia is based on 
evidence that SAH results in contraction of the extracellular and vascular spaces 
(168). Increasing CO with intravascular volume expansion would augment CBF (67). 
Hemodilution affects blood viscosity and improves the microcirculation rheology 
(260). Combination therapy of hypervolemia, hemodilution and hypertension is called 
“triple-H therapy” (197). 
Several observational studies have shown triple-H treatment to be effective in 
preventing or reversing DID (10, 132, 197). However, no conclusive randomized trials 
have been conducted to demonstrate the efficacy of triple-H treatment (57, 158). 
High costs and the potentially high rate of severe complications associated with 
triple-H therapy, including pulmonary edema, myocardial ischemia and cerebral 
swelling have been emphasized (57, 244). Avoidance of hypovolemia is 
recommended while triple-H therapy should be given only in case of symptomatic 
VSP (158). 
A synthetic nonhormonal 21-aminosteroid acting against free radical generation 
and lipid peroxidation might be effective in improving overall outcome in patients 
following SAH (130). However, the positive effect was seen only in men and it could 
not be repeated in a parallel study (95).  
 
8. Other complications of subarachnoid hemorrhage 
 
8.1. Hydrocephalus 
 
Acute hydrocephalus is frequently associated with SAH. In the International 
Cooperative Study on the Timing of Aneurysm Surgery (135), early hydrocephalus 
was initially noted in 15% of the overall population (3521 patients). During the course 
of treatment 18% of the patients received ventricular CSF drainage, 8% had lumbar 
CSF drainage and finally 8% received a permanent shunt device (135). 
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Correspondingly in the prospective aneurysm study of Säveland et al. (236), 27 of 
325 (8%) patients with SAH required shunt placement. In the surgical series of 835 
consecutive patients with aneurysmal SAH, Tapaninaho et al. (252) reported a 
frequency of 35% of early hydrocephalus. Ten percent of patients finally developed a 
shunt-dependent hydrocephalus. Severe bleeding, into the CSF cisterns or 
intraventricularly, was the basic prognostic factor in the development of chronic 
hydrocephalus. Shunt-dependent hydrocephalus had a clear adverse effect on 
outcome. 
  
8.2. Seizures 
 
There was frequency of 4.5% in the occurrence of seizures during the primary 
hospital course in the International Cooperative Study on the Timing of Aneurysm 
Surgery (135). In the series of Hernesniemi et al. (101, 189), epilepsy was seen in 
approximately 14% of patients with acute aneurysmal SAH treated surgically who 
were still alive two months following treatment (101). Keränen et al. (137) reported an 
overall frequency of 14% of late epilepsy in surgically treated patients with 
supratentorial aneurysms; 2.5% in patients with preoperative Hunt&Hess grade I and 
33% in patients with Hunt&Hess grade III-V. Ukkola et al. (266) reported a lower 
frequency of 8% of secondary epilepsy in their series of 183 consecutive patients 
operated on for ruptured aneurysms. They noted that the development of secondary 
epilepsy was associated with MCA aneurysms, temporary clipping during surgery, 
the wrapping technique used to treat the aneurysm and postoperative angiographic 
VSP. 
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AIMS OF THE STUDY 
 
The general aim of the study was to compare the safety, efficacy and outcome of 
endovascular and surgical therapy in the treatment of acutely ruptured intracranial 
aneurysms. 
 
The more specific aims were: 
 
1. To compare early safety and efficacy of endovascular and surgical treatment of 
acutely ruptured intracranial aneurysms. I 
 
2. To determine the differences between endovascular and surgical treatment 
modalities in long-term clinical, neuropsychological and radiological outcome. II 
 
3. To evaluate splanchnic tissue perfusion by gastric tonometry immediately after 
endovascular or surgical treatment in order to detect the disturbances and 
differences in splanchnic tissue perfusion that occur after either treatment. III 
 
4. Single photon emission tomography (SPECT) evaluation of the differences in 
brain perfusion that occur before and after endovascular or surgical treatment of 
ruptured intracranial aneurysms. IV 
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PATIENTS AND METHODS 
 
1. Study design and patient selection 
 
The study design was approved by the Ethical Committee of the Kuopio University 
and Hospital. During the study period between February 1, 1995 and August 31, 
1997, all patients who were admitted to our university hospital because of primary 
SAH were evaluated as potential candidates for the present prospective randomized 
study. Since the start of the study until February 1997, the study protocol included a 
repeated SPECT for the patients. During a period between May 1, 1995 and August 
31, 1996 the study protocol also included splanchnic tissue perfusion evaluation by 
gastric tonometry. 
After diagnosis of SAH by CT and obtaining informed consent from the patient 
or from the patient’s closest relative, the first SPECT was scheduled before any 
treatment for ruptured intracranial aneurysm. The final enrollment into the study was 
made after the diagnostic angiography. All patients with ruptured intracranial 
aneurysms considered suitable for both endovascular treatment and surgical clipping 
were consecutively included provided that none of the following exclusion criteria was 
fulfilled: 1. Age >75 years; 2. Bleeding >3 days previously; 3. Large hematoma 
necessitating surgery; 4. Mass effect causing neurological deficit; 5. The ruptured 
aneurysm had been previously operated on. The aneurysm was not considered as 
suitable for endovascular treatment and randomization if the diagnostic angiography 
revealed (a) the neck of the aneurysm to be wider than the fundus, (b) the aneurysm 
to be fusiform, (c) the neck and its relationship to the parent vessel and adjacent 
branches to be not distinguishable, or (d) the size of the aneurysm to be < 2 mm 
(less than the smallest coil available). The patient’s suitability for randomization and 
endovascular treatment was always considered according to the morphology of the 
aneurysm that had most probably ruptured (aneurysm irregularity, size and findings 
in computerized tomography (CT)).  
Stratified randomization was used to avoid selection bias. Sealed envelopes 
were allocated for each group of patients according to their pre-treatment clinical 
grades (Hunt & Hess Grade I-II, Grade III, and Grade IV-V patients). After the 
procedure, both the endovascular and surgical patients were treated in the ICU and 
in the neurosurgical ward in a similar manner. Systemic hemodynamics, oxygen 
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transport and gastric mucosal perfusion, assessed by gastric tonometry, were 
measured during the first four hours and between 6 and 12 hours after endovascular 
or surgical treatment. 
Symptoms of VSP were recorded on a daily basis. The second SPECT was 
scheduled 7 days after SAH. Follow-up angiography was scheduled after surgical 
clipping during the primary hospitalization, and in case of a minor neck-remnant, 12 
months after clipping and 3, 12 and 36 months after endovascular treatment. Clinical 
outcome assessment according to GOS and comprehensive neuropsychological 
examination were scheduled 3 and 12 months after SAH. MRI of the brain was 
scheduled 12 months after treatment. 
 
2. Diagnostic angiography and embolization procedure 
 
Diagnostic angiography was performed via the femoral route through a 6 F introducer 
and using DSA equipment with a 1024 x 1024 matrix (Siemens Polytron, Siemens 
Medical Engineering Group, Erlangen, Germany). Angiography was usually 
immediately followed by randomization and, if indicated, endovascular treatment in 
the same session. In angiography, the site, orientation and morphology of the 
aneurysm were carefully evaluated and the size of the aneurysm and the width of the 
neck were measured with a digital caliper using two coins as the reference.  
All the embolization procedures were performed under balanced anesthesia or 
sedative medication by one of two interventional neuroradiologists (TS or RV) or 
both. A 6 F guiding catheter was advanced to the ICA near the level of the skull base 
or to the upper cervical portion of the vertebral artery. A Tracker-10 or Tracker-18 
microcatheter with 2-tip-markers and a Dasher-14, usually followed by a Dasher-10 
guidewire (Target Therapeutics, Fremont, CA) were used for hyperselective 
catheterization of the aneurysmal sac. The distal end of the microcatheter was 
shaped with steam to tailor the vascular geometry before catheterization. Using 
digital road mapping control, care was taken not to touch the aneurysmal wall with 
the guidewire or catheter. Intra-aneurysmal angiograms were not performed. A 
continuous pressurized flush of heparinized saline was maintained in both the 
guiding catheter and the microcatheter.  
The sac was then filled with GDC coils (GDC-10, GDC-10 soft or GDC-10 2-
Diameter coils, Target Therapeutics, Fremont, CA) (Guglielmi). Complete occlusion 
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of the aneurysmal sac and neck was always attempted. The largest coil, selected 
according to the measured aneurysm diameters, was positioned first to form a 
basketlike frame in the aneurysm. The smaller coils were thereafter sequentially 
delivered inside the aneurysm, until the lumen was completely occluded and flow 
inside the aneurysm as well as in the secondary pouch was arrested. In aneurysms 
with an oblong or irregular shape, filling was started at the ruptured site when this 
was identifiable, usually in the dome of the aneurysm. If the size of the selected coil 
proved unsuitable, the GDC system allowed the removal of the coil as well as 
repositioning of the mesh to an optimal position. 
 
3. Surgery 
 
The surgical operations were performed under balanced anesthesia by a team of 7 
neurosurgeons (JH 26 cases, JR 10, ML 9, SS 5, AR 3, MVA 2 and MVI 2 cases) 
with a collective operative experience of approximately 2000 aneurysm operations. 
The principal investigator (TK) was not involved in surgery. A pterional, subtemporal, 
frontal interhemispherical or lateral suboccipital approach was used depending on 
the location of the aneurysm. A standard microsurgical method was used for clipping 
the aneurysmal neck with a Sugita or Aesculap clip. If feasible, the aneurysm was 
opened and/or coagulated. Hyperventilation was used routinely. All patients received 
corticosteroids and mannitol.  
 
4. Patient care 
 
In all of the Grade IV-V patients and in a majority of the Hunt & Hess Grade III 
patients, embolization was performed under general anesthesia. In Grade I-II and 
some Grade III patients, no sedation was applied. During the procedure, systemic 
heparinization (5000 IU initial bolus for the first 5 patients and 2500 IU for the rest, 
followed by 1000 IU after an hour and according to the measured activated clotting 
time thereafter), nimodipine and steroid as well as aspirin (500 mg orally or via a 
nasogastric tube) were used. 
Regardless of the method of securing the ruptured aneurysm, every patient was 
treated in a similar manner with hypervolemia, prolonged bed rest (10 days as a 
routine protocol in order to prevent orthostatic hypotension), glucocorticoids and 
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intravenous nimodipine. In the ICU, hypervolemia was ascertained by Swan Ganz 
catheter and measurement of the pulmonary artery wedge pressure. Ventricular 
drainage was performed immediately after embolization, when indicated. 
Heparinization was not routinely continued in the ICU. Oral aspirin (250 mg daily) 
was continued for three months after embolization. 
 
5. Treatment of the non-ruptured aneurysms 
 
Twenty-eight (26 %) patients had altogether 43 additional unruptured aneurysms. 
The additional aneurysms were treated in the same operation, when possible, in the 
surgical group, and by embolization after the acute phase of SAH in the 
endovascular treatment group if they were suitable for embolization. So far, 22 
additional unruptured aneurysms in 15 patients have been operated on, 2 unruptured 
aneurysms in two patients have been embolized, 4 patients with 8 additional 
aneurysms are dead, 3 patients with 3 aneurysms are severely disabled and the 
remaining 8 aneurysms in 4 patients are under angiographic follow-up. 
 
6. Intensive care unit monitoring and gastric tonometry 
 
A pulmonary artery catheter and gastric tonometer were inserted before or 
immediately after treatment. Gastric intramucosal pCO2 was measured by a saline 
tonometer after 30-90 minutes of equilibration (Tonometrics, Instrumentarium, 
Helsinki, Finland). The patients received an intravenous infusion of 5% glucose. 
None of the patients received enteral feeding. The correct position of the tonometer 
was confirmed by chest x-ray. The time corrected gastric mucosal pCO2 was 
obtained by multiplying the measured saline pCO2 by the correction factors 
determined by the manufacturer for equilibration times of 30-90 min. The pCO2 gap 
was calculated as gastric intramucosal pCO2 - arterial pCO2. The pHi was calculated 
by a modification of the Henderson-Hasselbach equation. Blood gas analyses and 
pCO2 values from tonometer were corrected for core temperature and measured by 
ABL 500 Blood Gas System (Radiometer A/S, Copenhagen, Denmark). Cardiac 
output was measured by thermodilution in triplicate using 10 ml saline at room 
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temperature. Plasma lactate concentrations were measured enzymatically (Stat Plus 
2300, Yellow Springs Instrument Co., Ohio, USA). 
 
7. Single photon emission tomography 
 
Regional cerebral perfusion was measured both preoperatively and postoperatively 
with a Siemens MultiSPECT3 gamma camera equipped with fan beam collimators 
(Siemens Medical Systems Inc., Hoffman Estates, Ill., USA) and using 99mTc-ethyl-
cysteine-dimer (99mTc-ECD; Neurolite, DuPont Pharma/Durham APS, Kastrup, 
Denmark) as the blood flow tracer. During the study period, SPECT was available 
during working days from 8 a.m. to 19 p.m. and on Saturdays from 8 a.m. to 14 p.m., 
but not on Sundays or national holidays. 99mTc-ECD was injected into the patient’s 
antecubital vein 30-45 min before the SPECT acquisition was started. A full 360° 
rotation was obtained (40 views/head, each for 35 s, matrix size 128 x 128) resulting 
in 6-8 million counts. The imaging resolution was 7 - 8 mm. Transaxial slices (3 mm 
thick) oriented by the orbito-meatal line were reconstructed using a filtered back 
projection technique (Butterworth filter: order 6 and cut-off frequency of 0.55 cm-1). 
Chang’s correction method of the tissue attenuation was applied with a uniform 
attenuation coefficient of 0.12 cm-1. Two consecutive slices were combined to obtain 
a slice thickness of 6 mm and then saved onto a hard disk for further analysis. 
The saved slices were prepared for the analysis of the ROIs by using a 
semiautomatic brain quantification program from Siemens. First, the slices were 
rotated and realigned according to orbito-meatal line so that the transaxial (x-
direction), sagittal (y-direction) and coronal (z-direction) slices were at 90° angles to 
each other. Secondly, the ROIs were drawn with a 45 % threshold on the aligned 
transaxial slices on the right and then mirrored to the left. For temporal ROIs, 
transaxial slices were reangulated (30°) according to the temporal lobe. To minimize 
the possible effect of crossed cerebellar diaschisis, all regional counts (per voxel) 
were normalized to average cerebellar tracer uptake, which was presumed to be 
least affected by the SAH (159). Normalization was achieved by dividing the average 
counts of each ROI by the mean cerebellar counts (cortico-cerebellar ratio, CCR).  
The following ROIs were determined on each side: frontobasal cortex, frontal 
cortex, pericallosal area, temporal apex, temporal cortex, parietal cortex and occipital 
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cortex. The control group had identical ROIs defined, except for the pericallosal area 
(Figure 1, Study IV). The analyses of the SPECT images included also visual 
evaluation by two nuclear medicine specialists (EV, JK). The readers were blinded to 
the mode of treatment and to other imaging findings. The size (no defect / small / 
medium/ large), severity (no defect / mild to moderate / severe), location (anterior / 
middle / posterior cerebral artery territory on any combination) and side of possible 
perfusion defect were recorded. In discrepant cases, a consensus was reached 
between the readers. 
 
8. Follow-up 
 
Clinical outcome at 3 months after treatment was evaluated by the neurosurgeon 
primarily responsible for treatment or the principal investigator (TK) of the study who 
was not involved in the surgery. The twelve-month outcome was evaluated by a 
single neurosurgeon (TK). The last outcome data obtained by telephone interview 
was evaluated by a single neurosurgeon (TK) or by a single trained nurse. 
Neuropsychological assessment was performed by the same neuropsychologist 
(Heleena Hurskainen) on three occasions. The short-term assessment 10 days after 
treatment was limited to a few tests. The comprehensive evaluation 3 and 12 months 
after treatment included tests of general intelligence, memory and selected language 
abilities and assessment of attention and flexibility of mental processing. In the tests 
of learning and memory, parallel sets of tests were used to minimize the retest 
learning effects, and the order of the sets was randomly alternated.  
The follow-up angiography was performed after surgical clipping during the 
primary hospitalization, and in case of a minor neck-remnant, 12 months after 
clipping and 3, 12 and 36 months after endovascular treatment. The achieved 
angiographic occlusion rate of the aneurysms was evaluated by consensus by a 
neurosurgeon (TK) and an interventional neuroradiologist (RV). 
In MRI, T2- and proton density-weighted transaxial slices of the brain were 
evaluated by a neuroradiologist (RV) and a neurosurgeon (TK) by consensus. The 
following factors were analyzed: 1.The presence, number and dimensions of 
ischemic lesions a) in the vascular territory of the parent artery of the ruptured 
aneurysm and b) in other vascular territories; 2.Traces indicative of mechanical 
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retraction injury; 3.Lesions caused by hematoma; 4.Lesions already present in the 
initial CT examination; and 5.Ventricular-to-intracranial width ratio. 
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9. Patients 
 
9.1. The whole study population (Studies I-II) 
 
During the study period, 321 patients were admitted to the hospital because of 
primary SAH. Twenty-four patients did not undergo angiography and were treated 
conservatively because they were in a moribund state. Of the remaining 297 patients, 
47 had negative angiograms and 8 had arteriovenous malformations. Of the 242 
consecutive patients with angiographically proven aneurysmal SAH, 131 were not 
randomized (Table 5). 
Altogether 111 patients were randomized. Two patients were excluded from the 
analysis after randomization (one from both treatment groups). In both cases, the 
decision to randomize the patient had been mistakenly based on the characteristics 
of an unruptured aneurysm while the ruptured aneurysm, partially or totally 
thrombosed and misinterpreted in the initial diagnostic angiography, was not suitable 
for either treatment modalities. The basic characteristics of the 109 patients included 
in the analyses are shown in Table 6.  
 
9.2. Study III population 
 
During the substudy period between May 1, 1995 and August 31, 1996, 56 patients 
were randomized for treatment. Twenty-six patients (13 endovascular / 13 surgical) 
were included into the study (Table 6) and 30 patients (14 endovascular / 16 surgical) 
were excluded because they did not tolerate the stiff gastric tonometry tube. 
 
9.3. Study IV population 
 
Since February 1, 1995 until February 28 1997 the study protocol included a 
repeated SPECT for the patients. During the 2-year SPECT-study period, 81 patients 
were randomly assigned for either treatment. Of these consecutive patients, 35 (17 
endovascular and 18 surgical patients) were excluded because the first SPECT study 
was not available (14 endovascular patients and 17 surgical), the patients died early 
(1 in both treatment groups), severe post-treatment bleeding (1 endovascular patient) 
or the patient refused (1 endovascular patient). Altogether 46 patients (22 in the 
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endovascular and 24 in the surgical treatment group) underwent the first SPECT 
before any treatment for the ruptured aneurysm as well as the postoperatively 
scheduled second SPECT approximately one week after treatment and were 
included in the present study. The basic characteristics of the patients are shown in 
Table 6. The control group for quantitative SPECT consisted of 10 healthy individuals 
(2 men and 8 women, mean age 40 years; range 27-55 years).  
 
Table 5. Excluded patients from the consecutive 242 patients with proven 
aneurysmal SAH. 
 
Reason for exclusion Number of patients (%) 
  
Large hematoma 35 (26.7) 
Aneurysm morphology, 
not suitable for coiling 
33 (25.2) 
 
> 72 h from bleeding 26 (19.9) 
Age > 75 years 11 (  8.4) 
Patient in moribund state 9 (  6.9) 
Coil therapy not available 6 (  4.6) 
Previous aneurysmal SAH 3 (  2.3) 
Aneurysm location,  
not suitable for ligation 
2 (  1.5) 
Aneurysm causing mass effect 2 (  1.5) 
Patient refused 2 (  1.5) 
Patient from abroad 2 (  1.5) 
Total 131 (100.0) 
  
Locations of the aneurysms  
in excluded patients 
Number of patients (%) 
ACA 34 (26.0) 
MCA* 59 (45.0) 
ICA 27 (20.6) 
VBA 11 (  8.4) 
Total 131 (100.0) 
Note: *significantly more often associated with large hematoma (p<0.001) 
MCA = middle cerebral artery 
ACA = anterior cerebral artery, anterior communicating artery, pericallosal artery 
ICA = internal carotid artery, ophthalmic artery, posterior communicating artery,  
anterior choroidal artery 
VBA = vertebrobasilar arteries 
 
 
Table 6. Basic characteristics of the study subjects. 
Studies I-II (n = 109) Study III (n = 26) Study IV (n = 46)  
Endovascular
group  Surgical group 
Endovascular 
group  Surgical group 
Endovascular
group  Surgical group 
Characteristic No. of Pts (Total 52) P 
No. of Pts 
(Total 57)
No. of Pts 
(Total 13) P 
No. of Pts 
(Total13)
No. of Pts 
(Total 22) P 
No. of Pts 
(Total 24) 
Male / Female  28 / 24 0.758 23 / 34 7 / 6 0.695 6 / 7 12 / 10 0.758 12 / 12 
Age (years (mean (range)) 49 (16-73) 0.553 50 (14-75) 52 (36-72) 0.868 53 (14-75) 49 (24-72) 0.553 52 (14-75) 
Hunt & Hess grade  0.748    0.121  0.748  
  I-II 31  36 3   7 13  16 
  III 12  14 5   4 7  5 
  IV-V 9  7 5   2 2  3 
Fisher grade  0.191    0.803  0.191  
  1-2 20  22 3   4 11  8 
  3-5 32  35 10   9 11  16 
Pre-treatment 
hydrocephalus  0.142    0.166  0.142  
  No 26  36 3   7 9  16 
  Moderate 23  17 9   5 12  6 
  Severe 3  4 1   1 1  2 
Aneurysm site  0.437    0.138  0.437  
  ICA 12  12 1   4 4  6 
  MCA 7  12 2   3 3  5 
  ACA 27  28 7   4 12  10 
  VBA 6  5 3   2 3  3 
Aneurysm size   0.358    0.108  0.358  
  Small  (2-7 mm)  39  41 11   11 18  16 
  Medium  (8-14 mm)  13  15 2   1 4  7 
  Large  (15-24 mm)  0  1 0   1 0  1 
Neck size   0.270    0.626  0.270  
  Small  (<4 mm) 38  46 11   10 16  15 
  Wide  (≥4mm)  14  11 2   3 6  9 
Note: P = Statistical difference between the treatment groups 
MCA = middle cerebral artery, ACA = anterior cerebral artery, anterior communicating artery, pericallosal artery 
ICA = internal carotid artery, ophthalmic artery, posterior communicating artery, anterior choroidal artery, VBA = vertebrobasilar arteries
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10. Statistics 
 
All analyses were performed with the statistical package SPSS for Win, Versions 
6.01–9.01 (SPSS Inc., Chicago, Ill., USA) by the principal investigator of the study 
(TK) consulting the statistician (PH). The intention-to-treat analysis was used in all 
comparisons of endovascular and surgical patients. In addition to intention to treat 
analyses, the statistical analyses were performed leaving out the patients having 
undergone crossover treatment to verify the statistical significance of the results. 
In general, all continuous variables were tested for normal distribution with the 
Kolmogorov-Smirnov 1-sample test (level of statistical difference at P<0.1). The 
Mann-Whitney U test for continuous variables with non-normal distribution or ordinal 
scale variables was used for group comparisons in the case of two independent 
samples, and the Wilcoxon Signed Ranks Test in the case of two related samples. 
Chi-square test was used for dichotomized discrete variables and the Student’s t-test 
for continuous variables with normal distribution for group comparisons in case of two 
independent samples. The paired samples t-test was applied for two related 
samples. Differences were considered to be statistically significant if the two-tailed p-
value was below 0.05.  
In Studies I-II and IV, potential predictors that showed statistically significant 
associations with the clinical outcome (GOS) of the patients in univariate analyses 
were further included in a stepwise multiple logistic regression analysis. A stepwise 
model-building procedure was performed for the parameters, using p<0.25 achieved 
in univariate analysis. In the final multivariate analysis, the statistical level of 
significance was set at p<0.05. Significance was calculated by the likelihood ratio 
test. The goodness of fit of the model was estimated with Nagelkerke-R2.  
In Study II, the subgroups of patients were compared in terms of time to a 
primary endpoint event, using Kaplan-Meier survival analysis and the Log Rank test. 
In Study III each measurement was used two times for two separate 
comparisons, i.e. endovascular vs. surgical and Hunt&Hess grade I-II vs. grade III-V. 
Significant effects of time-group interaction were identified by the Independent 
Samples T-test or the Mann-Whitney U-test after calculating new test-variables 
representing the differences between the first and second samples, each new test 
variable being used two times for two separate comparisons as well. In Study IV, 
each numerical SPECT parameter (cerebro-cerebellar ratios in different ROIs) was 
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used three times for separate comparisons, i.e. endovascular vs. surgical group and 
patients vs. controls in the second SPECT, and first SPECT vs. second SPECT 
within the treatment groups. Each recoded (ipsilateral or contralateral according to 
the side of the ruptured aneurysm) numerical SPECT parameter was used twice for 
two separate comparisons, i.e. ipsilateral vs. contralateral sides and the first SPECT 
vs. second SPECT within the treatment groups. The multiple comparisons were 
corrected with Bonferroni adjustment (191) and the significant P -value in the 
analyses using the same parameter twice was 0.05 / 2 = 0.025 and in the analyses 
using the same parameter three times was 0.05 / 3 = 0.017.  
The sensitivity and the specificity of the visually analyzed second SPECT in 
corroboration of the clinical diagnosis of VSP or in predicting late ischemic deficits in 
the MRI were analyzed, as well as the positive (PPV) and the negative (NPV) 
predictive values, and the overall accuracy of the SPECT 2 (287). Ninety five percent 
confidence intervals (95% CI) for the accuracy percentages were computed. 
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RESULTS 
 
1. Comparability of the study groups 
 
The endovascular and surgical treatment groups in none of the Studies I-IV showed 
any statistically significant differences in their age or gender distribution, or in the 
Hunt & Hess grades, Fisher grades or frequency of hydrocephalus in pre-treatment 
CT. Furthermore, there was no significant difference between groups according to 
the site or size of the ruptured aneurysm (Table 6).  
In Study III the patients in poor condition (pre-treatment Hunt&Hess grade III-V) 
were older than the patients in good condition (pre-treatment Hunt&Hess grade I-II) 
(p=0.126). The patients in poor condition were treated sooner after SAH (26 ± 12 vs. 
42 ± 21 hours; p=0.043) (Table, Study III).  
In Study IV, the time intervals from SAH to treatment and to the first and the 
second SPECT were comparable (Table 2, Study IV). Individuals in the control group 
were younger (mean age 40 years; range 27-55 years) than patients in the 
endovascular (mean age 49 years; range 24-72 years) (P=0.022) and surgical group 
(mean age 52 years; range 14-75 years) (P=0.017).  
The numbers of patients completing all the neuropsychological tasks, their 
ages, gender and years of formal education were equal in both treatment groups 
(Table 7). The proportion of patients undergoing MRI did not significantly differ 
between the treatment groups in either Study II or Study IV populations (Table 8).  
 
2. Technical complications of endovascular treatment 
 
One incompletely occluded MCA aneurysm rebled on the first day following 
embolization. The large intracerebral hematoma was immediately evacuated. 
However, the patient died within two weeks after the hemorrhage (Table 9). Another 
patient had his MCA aneurysm totally occluded under general anesthesia. The 
aneurysm seemed to be totally occluded, however, a previously nondiagnosed 
intracerebral hematoma was detected immediately after the procedure (Table 9). The 
aneurysm had possibly ruptured before embolization in this already anesthized 
patient. Despite immediate surgical evacuation of the hematoma and ligation of the 
aneurysm, the patient remained severely disabled. After these two cases early in the 
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study, the heparin bolus was reduced from 5000 IU to 2500 IU. In three cases, the 
aneurysmal wall was perforated during coil delivery (Table 9). In one patient with an 
MCA aneurysm, coil delivery was successfully continued, and he made a good 
recovery. In two unanesthetized patients, perforation was followed by severe 
 
Table 7. Neuropsychological test scores (± SD) at 12 months after SAH in patients 
having good outcome according to the Glasgow Outcome Scale (GOS V). 
 
Test Embolization (N = 38) Surgery (N = 37) P 
    
Verbal IQ§ 99.0 ± 16.5 97.0 ± 16.7 0.198 
Performance IQ§ 106.3 ± 16.6 106.4 ± 20.2 0.998 
Memory (MQ) 112.2 ± 18.2 110.0 ± 17.3 0.526 
Story recall:  immediate 9.3 ± 3.3 8.6 ± 3.9 0.429 
Story recall:  delayed 8.1 ± 3.2 7.5 ± 3.8 0.501 
Visual reproduction:  immediate 10.9 ± 2.9 10.6 ± 3.0 0.620 
Visual reproduction:  delayed 8.3 ± 4.3 7.0 ± 4.2 0.178 
Rey, reproduction  delayed 12.4 ± 5.4 12.5 ± 6.8 0.948 
Digit Span 12.8 ± 4.0 12.5 ± 3.4 0.750 
Word fluency 38.3 ± 16.1 36.1 ± 12.5 0.510 
Boston naming 23.7 ± 3.8 22.4 ± 4.4 0.180 
Stroop A (s) 31.1 ± 26.5 27.8 ± 6.8 0.462 
Stroop B (s) 38.3 ± 26.2 34.8 ± 10.4 0.449 
Stroop C (s) 69.1 ± 37.0 67.3 ± 23.4 0.802 
Trail making A (s) 46.8 ± 34.7 45.8 ± 24.9 0.892 
Trail making B (s) 132.6 ± 83.8 128.5 ± 73.6 0.824 
Tapping dominant hand (/10s) 49.6 ± 9.8 48.5 ± 9.1 0.627 
    
Age 46.8 ± 14.3 49.2 ± 13.2 0.455 
Years of education 9.6 ± 3.2 9.6 ± 3.0 0.959 
Gender (F / M) 16 / 22 23 / 14 0.107 
Days from SAH 438 ± 107 460 ± 216 0.576 
 
Note: P- value indicates statistical difference between patients in different treatment groups.
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restlessness or convulsions and unconsciousness, prohibiting further delivery of 
coils. The latter patients were subsequently operated on and recovered uneventfully. 
Extrusion of coils from the aneurysm neck occurred in three patients (Table 9).  
In one patient with an ACoA aneurysm, protruding coils caused a slight 
 
Table 8. Occurrence of clinical symptoms of vasospasm (VSP) and radiological 
(MRI) outcome of the patients. 
 
Follow-up 
Endovascular 
group (n = 52)
P 
Surgical group 
(n = 57) 
    
Clinical symptoms of VSP (n (%))  0.556  
No symptoms 28 (54)  29 (51) 
Gradual deterioration only (possible VSP) 10 (19)  8 (14) 
Sudden deterioration and / or focal  
neurological symptoms (probable VSP) 
14 (27)  20 (35) 
    
12-month MRI findings (n (%))    
MRI-study performed (total) 40 (77)  47 (83) 
Ventricular/intracranial width ratio 0.24 ± 0.07 0.936 0.24 ± 0.08 
Ischemic deficits    
    Parental artery territory 8 (20) 0.018 21 (45) 
Mean diameter (mm) 43 ± 40 0.624 36 ± 31 
    Other vascular territory 9 (23) 0.521 8 (17) 
Mean diameter (mm) 30 ± 29 0.152 52 ± 30 
    Mean diameter of all ischemic deficits (mm) 39 ± 36 0.382 41 ± 30 
Superficial brain retraction deficits 4 (10) < 0.001 21 (45) 
Deficit caused by preoperative ICH 10 (25) 0.862 11 (23) 
Previous lesions    
    cortical infarctions 1 (3) 0.460 0 (0) 
    lacunar infarctions 1 (3) 0.621 3 (6) 
    atrophy 1 (3) 0.621 3 (6) 
    chronic white matter lesions 7 (18) 0.843 9 (19) 
 
Note: P-value indicates the statistical difference in results between the treatment groups. 
Values are numbers of patients (%) unless otherwise indicated.  
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Table 9. Acute technical complications associated with either surgical or endovascular treatment. 
 
Intended 
Modality of 
Treatment 
Hunt&Hess 
Grade 
Site 
Aneurysm 
Size mm 
Neck 
mm 
Complication   
        
Treatment Outcome
Embolization II MCA 12 3 Coil migration 2cm ICU GR 
Embolization II MCA 7 4 Hematoma (possible perforation) Surgery SD 
Embolization IV MCA 6 3 Rebleeding after failed occlusion Surgery Death 
Embolization       
      
      
       
       
        
III 12 3 Perforation Coil delivery GR
Embolization II ACom 3 2 Perforation Surgery GR
Embolization II ACom 5 4 Parent vessel obstruction Heparin, surgery GR 
Embolization III ACom 4 2 Coil protrusion ICU VS
Embolization II Peric 8 3 TIA ICU GR
Embolization II Peric 3 2 Perforation Surgery GR
Surgery II CoP 7 2 Clip kinking after ligation, transient hemiparesis Re-surgery MD 
Surgery II MCA 5 3 Rupture during ligation preceding severe brain oedema ICU Death 
Surgery II MCA 6 2 Rupture during dissection ICU GR 
Surgery II Basil 12 4 Rupture during ligation, main vessel occlusion ICU Death 
MCA
 
Note: MCA = middle cerebral artery, ACom = anterior communicating artery, Peric = pericallosal artery 
TIA = transient ischemic attack, ICU = observation and monitoring in the intensive care unit 
GR = good recovery, MD = moderate recovery, SD = severe disability, VS = vegetative state 
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angiographical flow obstruction. Continuing heparin infusion in the ICU, however, 
resulted in thrombolysis of the aneurysm. The patient made a good recovery after 
surgical removal of the protruding coils and aneurysm ligation. In another case, coil 
protrusion from an ACoA aneurysm did not seem to cause any flow obstruction and 
no treatment was considered necessary. Later on, however, the patient developed 
severe VSP with no response to aggressive treatment, including balloon angioplasty, 
and the patient remained in a vegetative state. In a third patient with a medium-sized 
MCA aneurysm, the proximal end of the first coil moved into an MCA branch, without 
clinical consequences, and the aneurysm was successfully occluded.  
One patient with a left-sided pericallosal aneurysm had a transient paresthesia 
of the right leg during coil delivery without further clinical consequences (Table 9). No 
other obvious technique-related thromboembolic complications occurred in the 
patients.  
Four technical complications had no clinical consequences and required no 
therapy. In five cases which had additional direct surgery, three patients had good 
recovery, one had a severe disability and one patient died because of early 
rebleeding from the incompletely occluded aneurysm. Thus, morbidity as well as 
mortality due to the technique were 1/52 (1.9%).  
 
3. Technical complications of surgical treatment 
 
In two patients, the MCA aneurysm ruptured during an otherwise successful ligation 
(Table 9). One of these patients, developed severe MCA territory edema and died 
two days later. The other patient had also ischemic changes in the MCA territory in 
the postoperative CT, but made a good recovery. One patient with a PCoA aneurysm 
underwent immediate resurgery because of transient hemiparesis caused by a 
kinking clip (Table 9). One basilar bifurcation aneurysm ruptured during unsuccessful 
ligation resulting in early death (Table 9). 
One patient developed an abscess in the frontal lobe five months after ligation 
of an ACoA aneurysm, and surgical evacuation was required. This complication was 
not, however, directly related to the surgical ligation of the aneurysm since the 
abscess had developed on the site of external CSF drainage.  
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The four technical complications did not lead to permanent morbidity in two 
cases, but in two cases, the death of the patient was related to the technique. The 
mortality due to the technique was 2/57 (3.5 %). 
 
4. Primary angiographic results of the treatment 
 
The primary angiographic results achieved purely with the intended modality of 
treatment according to different aneurysm locations are shown in Table 10. The 
aneurysmal sac was completely obliterated with coils in the first session in 26 (50 %) 
of the endovascularly treated patients. Subtotal occlusion with a small neck remnant 
was achieved in an additional 18 cases (35 %) and some filling of the fundus of the 
aneurysm remained in 3 (6 %) cases. In five patients there was a failure to achieve 
endovascular treatment resulting in no occlusion of the aneurysm. Of the small 
aneurysms with a small neck, 61% were totally obliterated in the first session (Table 
10).  
The surgical results are not directly comparable with the endovascular results 
since early postoperative angiography was not performed in 7 patients. Fifty surgical 
patients underwent postoperative control angiography during the first hospitalization, 
and in 7 cases the occlusion rate was confirmed only on operation or at autopsy. The 
ruptured aneurysm was considered to be totally ligated in 42 (74%) cases. A small 
neck remnant was imminent in 9 (16%) aneurysms. In 5 (9%) cases, a significant 
residual part of the aneurysmal fundus remained open after surgery (Table 10).  
In the aneurysms located in the posterior circulation (n=11), the primary 
angiographic results proved to be significantly better in the endovascular treatment 
group (p=0.045), whereas in the ACA aneurysms (n=55), the morphologic results 
were significantly better in the surgical group (p=0.005). In the MCA (n=19) or ICA 
(n=24) aneurysms, no significant differences in the morphological results were seen 
between the treatment groups (Table 10).  
 
5. Cross-over between treatment groups during the primary hospitalization 
 
Eight patients (15%) underwent a crossover from endovascular to surgical treatment 
and one patient underwent a crossover from surgical to endovascular treatment 
 
 
 
Table 10. Primary and final angiographic results of early endovascular and surgical treatment of recently ruptured aneurysms according 
to the site of the aneurysm. 
 Endovascular treatment p Surgical treatment 
 Total
obliteration 
 Neck 
remnant 
Significant filling 
of fundus 
No 
occlusion
 
Total 
obliteration
Neck 
remnant 
Significant filling 
of fundus 
No 
occlusion 
Primary results‡          
All aneurysms 26 (50.0%) 18 (34.6%) 3 (5.8%) 5 (9.6%) 0.015 42 (73.7%) 9 (15.8%) 5 (8.8%) 1 (1.7%) 
Anterior circulation          
        
        
        
        
MCA 4 1 1 1 0.186 10 2 0 0
ACA 13 9 1 4 0.005 23 4 1 0
ICA 6 5 1 0 0.468 8 3 1 0
Posterior circulation 3 3 0 0 0.045 1 0 3 1
Final results§          
          
        
        
        
        
All aneurysms 40 (76.9%) 10 (19.2%) 2 (3.9%) 0 (0.0%) 0.413 49 (86.0%) 7 (12.3%) 0 (0.0%) 1 (1.7%) 
Anterior circulation
MCA 5 2 0 0 0.523 11 1 0 0
ACA 23 4 0 0 1.000 24 4 0 0
ICA 7 3 2 0 0.212 10 2 0 0
Posterior circulation 5 1 0 0 0.727 4 0 0 1
 
Note: p-value indicates statistical significance between treatment groups. 
MCA = middle cerebral artery, ACA = anterior cerebral artery, anterior communicating artery, pericallosal artery, ICA = internal carotid artery, ophthalmic 
artery, posterior communicating artery, anterior choroidal artery 
†Primary result is the result achieved with intended modality of treatment during the first hospitalization.  
§Final result is the last angiographic result available, including the patients with cross-over treatment and the patients who died.  
  The results improved significantly in both surgical (p=0.016) and endovascular (p=0.001) groups
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during the primary hospitalization. The patient selection for crossover treatment at 
different points of time and the outcomes according to the final modality of treatment 
are presented in Figure 1. 
As a result of the technical complications in the endovascular treatment 
described above, five patients underwent a crossover from endovascular to surgical 
treatment. One of these five patients died and four made good recoveries (Table 9). 
In addition, three patients had subsequent open surgery after failed attempts at 
endovascular treatment, the neck of the aneurysm proving to be too wide to retain 
the coils. These patients had their aneurysms completely occluded with clipping 
except for one patient with a wide-necked MCA aneurysm whose aneurysm was left 
with a neck remnant. All three patients with their wide-necked aneurysms 
subsequently ligated made good recoveries. 
One patient (2%) with an incompletely clipped ACoA aneurysm underwent 
embolization resulting in total occlusion. This patient required a permanent shunt-
device, but initially made a good recovery. However, two months after SAH, the 
patient died because of a large spontaneous intracerebral hematoma on a location 
remote from the ruptured aneurysm. 
 
6. Gastric tonometry 
 
In the whole Study III population, the mean pHi did not change between the first and 
second measurement periods (7.28 ± 0.12 and 7.29 ± 0.08, respectively) (Table 2, 
Study III). Furthermore, the pHi did not differ either between patients in endovascular 
and surgical groups or between patients with Hunt&Hess grades I-II and grades III-V 
(Table 2, Study III). In the whole Study III population the pCO2 gap also remained 
stable during the study period, 1.5 ± 1.9 kPa and 1.7 ± 1.2 kPa, respectively. No 
statistically significant difference was found in pCO2 gap between the different 
treatment groups (endovascular 2.2 ± 2.5 kPa vs. 1.9 ± 1.3 kPa, surgical 0.8 ± 0.5 
kPa vs. 1.5 ± 1 kPa), and the pre-treatment Hunt&Hess grade groups (Gr I-II 1.2 ± 
2.6 kPa vs. 1.8 ± 0.7 kPa, Gr III-V 1.7 ± 1.5 kPa vs. 1.7 ± 1.4 kPa) (Table 2, Study 
III). Individual changes in the pCO2 gap are shown in Figures 2 and 3. 
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n   n (%) 
1
First 
hospitalization
 
Gr I-II     32  
Gr III     14 
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ACA     27 
VBA       3 
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SD   3 (  5.7) 
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Figure 2. Individual changes in the difference between intramucosal and arterial pCO2 (pCO2 gap) within 4 hours and 6-12 hours 
after aneurysm treatment subdivided according to the treatment groups. The mean values (± Standard deviation) of measurements 
are included. 
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after aneurysm treatment subdivided according to Hunt&Hess grades. The mean values (± Standard deviation) of measurements 
are included. 
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6.1. Hemodynamic and oxygen transport data  
 
In the whole study III population, hemodynamic variables remained stable during the 
study but the plasma hemoglobin concentration decreased (p<0.001) (Table 3, Study 
III). Only for lactate was there any statistically significant time and treatment group 
interaction (p=0.012) as well as a time and Hunt&Hess grade interaction (p=0.020). 
However, the changes in hemoglobin and lactate concentrations were within the 
normal range. At the time of the first measurement, the Hunt&Hess grade I-II patients 
had lower arterial blood pHs (aBpH) than the Hunt&Hess grade III-V patients 
(p=0.013) (Table 2, Study III). At the time of second measurement, the surgical 
patients had lower saturated venous oxygen (SvO2) values than the endovascular 
patients (p=0.017) (Table 3, Study III). 
 
6.2. Clinical problems associated with subarachnoid hemorrhage 
 
No statistically significant difference between the treatment groups was observed in 
the number of patients with possible or probable clinical symptoms of VSP either in 
the whole study population or in the Study IV population (Table 8). Patients with 
probable VSP had extended fluid therapy and maximized medical therapy 
(nimodipine infusion) in addition to ward observation or triple-H therapy in the ICU. In 
the most severe cases angioplasty was applied with or without superselective 
injection of papaverine. All of the patients with possible VSP routinely underwent 
hypervolemic fluid therapy in the ward. 
In the whole study population, a permanent shunt-device because of 
hydrocephalus was required more frequently (p=0.045) in the surgical group (n=11; 
19%) than in the endovascular treatment group (n=3; 6%). 
There was no statistically significant difference in the frequency of extracerebral 
complications occurring in the course of treatment in ICU between the treatment 
groups in the Study III population. In the endovascular group, four patients each 
developed one extracerebral complication: sepsis, multiple organ failure, pneumonia 
and renal failure. In the surgical group, one patient developed pulmonary edema and 
one patient suffered from septic urinary infection.  
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7. Single photon emission computed tomography 
 
7.1. Visual analysis of single photon emission tomography 
 
In the SPECT performed before treatment there were only 8 (36.4%) patients without 
cerebral perfusion deficits in the endovascular group and 5 (20.8%) patients in the 
surgical treatment group (P=0.243) (Table 4, Study IV). Acute perfusion deficits 
preceding the treatment were thus common in both treatment groups and there was 
no significant difference in their size (P=0.380), severity (P=0.094), anatomical 
location (P=0.318) or lateralization (P=0.128).  
In the whole study population visual comparison between the SPECT 1 and 
SPECT 2 revealed that the perfusion deficits had increased in size (P=0.007) and 
become more profound (P=0.044) in SPECT 2. When the treatment groups were 
compared, there were no statistically significant differences in sizes, severity or 
locations of the perfusion deficits in the SPECT 1 or SPECT 2 (Table 4, Study IV). 
Within the surgical treatment group, comparison of the findings between the first and 
the second SPECT revealed that perfusion deficits increased in size (P=0.006) and 
became more often bilateral (P=0.020). In the endovascular treatment group, this 
comparison revealed no significant changes (Table 4, Study IV). 
 
7.2. Semiquantitative regional analysis of single photon emission tomography 
 
Twenty-two patients in the endovascular treatment group and 21 patients in the 
surgical group had sufficiently high quality of SPECT images to be included in the 
semiquantitative regional analysis. The comparison between treatment groups 
revealed no significant differences in CCRs in the SPECT 1 (Table 5, Study IV). In 
the left temporal apex, patients in both the endovascular (P=0.004) and the surgical 
(P=0.002) treatment groups had lower CCRs than the individuals in the control group.  
In the SPECT 2, surgical patients had decreased CCRs in the right frontobasal 
cortex (P=0.012) when compared to the CCRs in the endovascular patients. In the 
comparison between the control group and the treatment group, statistically 
significant differences in CCRs were detected only in the surgical group: in the left 
temporal apex (P=0.010) and in the right frontobasal cortex (P=0.014) (Table 5, 
Study IV). 
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In the surgical treatment group, but not in the endovascular group, comparison 
between the first and second SPECT revealed decreases in CCRs: in the right 
frontobasal cortex (P=0.003), right frontal cortex (P=0.012) and right pericallosal area 
(p < 0.001) (Table 5, Study IV) (Figure 4). 
 
7.3. Laterality of the ruptured aneurysm and regional cerebral perfusion 
 
The sides of the ROIs were further recoded as ipsilateral or contralateral according to 
the sides of the ruptured aneurysms. Twenty patients were included in each 
treatment group after exclusion of the midline basilar bifurcation aneurysms (Table 6, 
Study IV). No statistically significant differences were found between the ipsilateral 
and contralateral CCRs in the first SPECT in either treatment group (Table 6, Study 
IV).  
In the second SPECT in the surgical group, the ipsilateral CCRs were 
significantly lower in the frontobasal cortex (P=0.002), temporal apex (P=0.002) and 
the whole ipsilateral hemisphere (P=0.007) when compared with the contralateral 
CCRs (Table 6, Study IV). In the surgical group, the decrease in the ipsilateral CCRs 
between the first and second SPECT was statistically significant in the frontobasal 
cortex (P=0.000), frontal cortex (P=0.011), pericallosal area (P=0.002), and the whole 
hemisphere (P=0.003) (Figure 5). A statistically significant increase in the 
contralateral CCRs was found in the temporal apex (P=0.004) (Table 6, Study IV) in 
the endovascular treatment group.  
 
7.4. Association between single photon emission tomography and vasospasm 
 
Visually evaluated SPECT 2 scans were used in determining possible agreement 
between SPECT findings and clinical VSP. The SPECT findings were dichotomized 
according to size (no lesion or small lesion / intermediate or large lesion), and clinical 
VSP was dichotomized as no symptoms / possible or probable symptoms. The 
visually evaluated SPECT proved to have a sensitivity of 96% (95% CI, 88% to 
100%), specificity of 55% (95% CI, 34% to 75%), PPV of 70% (95% CI, 54% to 85%),  
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NPV of 92% (95% CI, 78% to 100%) and overall accuracy of 76% (95% CI, 64% to 
88%) for clinical VSP. The 2 x 2 contingency table used to calculate the diagnostic 
accuracy of SPECT in corroboration of the clinical diagnosis of VSP is shown in 
Table 7, Study IV. 
 
8. Angiographic follow-up  
 
8.1. Endovascular treatment group 
 
Altogether 39 patients treated exclusively endovascularly out of the 52 patients 
randomly assigned for endovascular treatment underwent control angiography at 
three months, and 34 corresponding patients at twelve months. Within the first twelve 
months six exclusively endovascularly treated patients had died, a total of 10 patients 
(19%) assigned for endovascular treatment had been operated on and one of them 
had died as well. Two patients refused to undergo the 12-month control angiography. 
The 12-month angiographic results of 34 patients treated by only endovascular 
means, included the assisted successful results of the complementary second 
embolization performed in 3 patients (twice in one case) and the results in 7 cases 
with spontaneous thrombosis of the neck remnant. In 26 (76%) cases, the aneurysm 
was angiographically totally obliterated, and a small neck remnant remained in 7 
(21%) aneurysms. In one (3%) aneurysm there was significant filling of the 
aneurysmal sac. 
Refilling of the aneurysm occurred in altogether 12 of 39 (31%) endovascularly 
treated patients during the first 12 months after the initial embolization. Spontaneous 
thrombosis of the aneurysm remnant occurred in 7 of 39 cases. In one patient, the 
aneurysm rest had spontaneously thrombosed in the three-month angiography, but 
this was found to have recanalized by the 12-month angiography. 
 
8.2. Surgical treatment group 
 
In the surgical treatment group, complete ligation of the aneurysm was ascertained 
with control angiography during the first hospitalization in 37 patients. These patients 
had no further angiographic follow-up. In two patients, complete ligation of the 
aneurysm was ascertained at the three-month angiography, in one patient in autopsy 
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(after early death), in one patient with magnetic resonance angiography in addition to 
the perioperative estimation and in one patient with peroperative estimation only.  
Incomplete surgical occlusion of the aneurysm was angiographically confirmed 
in 13 patients during the first hospitalization. One patient had autopsy after early 
death attributable to a failed ligation of the aneurysm and occlusion of the main 
vessels.In one patient the aneurysm was perioperatively estimated to be only partially 
occluded, but in the 12-month angiography the aneurysm proved to be totally 
occluded. One patient had autopsy after early death attributable to a failed ligation of 
the aneurysm and occlusion of the main vessels.In one patient the aneurysm was 
perioperatively estimated to be only partially occluded, but in the 12-month 
angiography the aneurysm proved to be totally occluded. One patient had resurgery 
with poor clinical outcome after 3-month angiography. In one patient, the aneurysm 
had undergone complete spontaneous thrombosis within the first three months. In 
five patients, a minor neck remnant remained unchanged in the 12-month 
angiography. One elderly patient refused to undergo the control angiography and one 
patient with nearly complete occlusion of the aneurysm died before the control 
angiography and had no autopsy 
Altogether four patients in the surgical treatment group had no control 
angiography. Eleven patients with incompletely clipped aneurysms underwent 
repeated angiography. One residual aneurysm had spontaneously thrombosed 
during the first three months. There was one residual of a basilar bifurcation 
aneurysm that increased in size during the follow-up. The reason why most of the 
surgical aneurysm remnants were followed-up without intervention was that those 
remnants were either very small or carried a high risk for either resurgery or 
endovascular crossover treatment. 
 
9. Delayed cross-over treatment  
 
Four patients underwent a delayed crossover from endovascular to surgical 
treatment and three patients underwent a delayed crossover from surgical to 
endovascular treatment. The overall frequency for crossover treatment was 
significantly higher in the endovascular group (n=12; 23%) than in the surgical group 
(n=4; 7%) (P=0.028) (Figure 1). 
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In the endovascular treatment group, one MCA aneurysm with an initial total 
occlusion was found to have recanalized by the three-month angiography. The 
residual aneurysm was successfully ligated and the patient made a good recovery. 
One patient had a minor neck remnant of the pericallosal artery aneurysm observed. 
In the three-month angiography, the aneurysm showed significant filling of the fundus 
and was successfully ligated. The patient made a good recovery. One ACoA 
aneurysm remained totally occluded for the first three months, but in the 12-month 
angiography neck of the aneurysm had been recanalized and the aneurysm was 
successfully operated on. The patient made a good recovery. An ICA bifurcation 
aneurysm with a small neck remnant increased in size during the first three months, 
and was found to be partly recanalized in the 12-month angiography. Attempted open 
surgical ligation did not succeed because the stiff coil mass hindered the appropriate 
clip positioning. Soon after operation, the patient developed a massive MCA 
infarctation, which resulted in his demise. 
One patient with only a partially ligated basilar bifurcation aneurysm was 
observed at the beginning. The residual aneurysm remained stable for the first three 
months but eventually increased in size during the next nine months. Embolization of 
the residual aneurysm resulted in a total occlusion and the patient made a good 
recovery. In another patient with a basilar bifurcation aneurysm only partially ligated, 
the three-month control angiography showed no change in the size of filling portion of 
the aneurysm. Embolization of the aneurysm remnant was, however, performed with 
a result of total occlusion. The patient remained severely disabled. The previously 
described patient who underwent immediate recraniotomy because of the clip 
obstructing the PCoA showed up with a stable neck remnant in the three-month 
angiography. This neck remnant was embolized resulting in total occlusion. The 
patient made a good recovery. 
 
10. Final morphological results according to intended modality of treatment 
 
The final morphological results are the last results available verified by angiography 
or by other means as described earlier. The final morphological occlusion rates 
include the results of 12 patients with the crossover treatment in the endovascular 
group and four patients with crossover treatment in the surgical group. The results 
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include also the results of the three patients with reembolization and the two patients 
with resurgery (Table 10).  
In comparison between the treatment groups, there were no statistically 
significant differences in either the overall final morphological occlusion rates or in 
the final morphological occlusion rates according to the sites of the aneurysms (Table 
10). The aneurysmal sac was completely obliterated in 40 (77 %) of the 
endovascularly treated patients. Subtotal occlusion with a small neck remnant was 
achieved in an additional 10 cases (19 %) and some filling of the fundus of the 
aneurysm remained in 2 (4 %) cases (Table 10). The ruptured aneurysm was 
surgically totally occluded in 49 (86%) cases (Table 10). A small neck remnant was 
detected in 7 (12%) aneurysms. In one (2%) case, the ligation was unsuccessful and 
the patient died before further attempts at securing the aneurysm (Table 10). 
 
11. Twelve-month clinical outcomes 
 
Neither treatment group significantly improved their clinical outcome between 3 and 
12 months after treatment (Table 11). According to the intention to treat, the twelve-
month clinical recovery of the patients in the endovascular and the surgical treatment 
groups was comparable according to the GOS (p=0.319) (Table 11). Forty-one (79%) 
patients initially randomized to the endovascular treatment group and 43 (75 %) 
patients randomized to the surgical treatment showed good or moderate recovery. 
Severe disability or vegetative state remained in 4 endovascular (8 %) and 5 surgical 
(9 %) patients, respectively. Seven patients (13%) died in the endovascular treatment 
group and 9 (16 %) in the surgical treatment group. There were no statistically 
significant differences in the outcome when the subgroups of patients with different 
anatomic aneurysm locations or initial Hunt&Hess or Fisher grades were analyzed 
separately (Table 11). 
In univariate analysis, the intended treatment modality, gender of the patient, 
crossover treatment and multiplicity of the intracranial aneurysms were not 
statistically significant determining factors of good recovery (GOS V). Since 
Hunt&Hess grade (p<0.001), postoperative symptomatic VSP (p<0.001), need for 
permanent shunt creation (P<0.001), Fisher grade (p=0.001), size of the aneurysm 
(p=0.003), age (p=0.015), size of the aneurysmal neck (p=0.024), and hydrocephalus 
in the preoperative CT (p=0.027) were significantly associated with clinical outcome,  
 
 
Table11. Twelve-month clinical outcomes (Glasgow Outcome Scale) of patients with early endovascular vs. surgical treatment 
(according to the intention to treat) of recently ruptured aneurysms by the initial Hunt & Hess grade, Fisher grade and aneurysm 
site. 
 Endovascular treatment (n = 52) p Surgical treatment (n = 57) 
 GR          MD SD VS Death GR MD SD VS Death
            
Total 40 1         
           
     
     
          
           
     
     
           
           
          
          
          
          
3 1 7 0.319 38 5 4 1 9
Hunt&Hess grade 
  I – II 28  2  1 0.283 29 3 1 3
  III 9 1   2 0.421 8 2 1 3
  IV - V 3 1 1 4 0.823 1 2 3
Fisher grade 
  0 - 2 18  1  1 0.361 17 2 3
  3 - 5 22 1 2 1 6 0.628 21 3 4 1 6
Aneurysm site 
Anterior circulation 
  MCA 5 1 1 0.845 7 2 1 1 1
  ACA 22 1 1 3 0.698 21 2 2 3
  ICA 9 2 1 0.604 8 1 3
Posterior circulation 4 2 0.740 2 1 2
 
Note: p-value indicates statistical significance between treatment groups. 
GR = good recovery, MD = moderate recovery, SD = severe disability and VS = vegetative state  
MCA = middle cerebral artery, ACA = anterior cerebral artery, anterior communicating artery, pericallosal artery 
ICA = internal carotid artery, ophthalmic artery, posterior communicating artery, anterior choroidal artery
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they were further included in a backward stepwise multiple logistic regression 
analysis as independent variables. Postoperative symptomatic VSP (OR, 2.47; 95% 
CI, 1.45 to 4.19; p<0.001), poorer Hunt&Hess grade (OR, 2.50; 95% CI, 1.31 to 4.75; 
p=0.005), need for permanent shunt creation (OR, 8.90; 95% CI, 1.80 to 44.15; 
p=0.008) and larger size of the ruptured aneurysm (OR, 1.22; 95% CI, 1.02 to 1.45; 
p=0.032) proved to be independent predictors of poorer clinical outcome. The R2 for 
the final model was 0.514. 
In univariate analyses among the whole study IV population (n=46) probable 
VSP (P=0.011), poor preoperative H&H Grade (P=0.001), higher Fisher Grade 
(P=0.013), larger size of the perfusion deficit in the second SPECT (P=0.002) and 
more profound perfusion deficit in the second SPECT (P=0.031) were significantly 
associated with clinical outcome. They were further included in a backward stepwise 
multiple logistic regression analysis as independent variables. The GOS was 
dichotomized as good outcome (GOS V) versus worse than good outcome (GOS I-
IV). Only poor H&H grade (OR, 7.75; 95% CI, 1.64 to 36.70; P=0.001) proved to be 
an independent predictor of poor clinical outcome. The R2 for the final model was 
0.564. 
 
12. Neuropsychological outcomes 
 
The number of patients completing all the neuropsychological tests, their ages, 
gender and years of formal education were equal in both treatment groups. Only 
patients who completed all of the tasks were included in the analysis. Of these 
patients, the number of patients with moderate or severe disability (GOS) was small 
and unequally distributed between the surgical and endovascular groups at both the 
3- (7 vs. 3) and 12-month (7 vs. 1) assessments. The number of tasks not performed 
did not significantly differ between the groups. 
Patients with good clinical outcome (GOS) in both treatment groups did not 
show any significant differences in any of their neuropsychological test scores, and 
both groups generally improved their performance between the 3- and 12-month 
assessments (Table 4, Study II).  
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13. Twelve-month magnetic resonance imaging of the brain 
 
Forty endovascular and 47 surgical patients (p=0.808) underwent MRI of the brain 12 
months after treatment (Table 8). Claustrophobia prohibited MRI examination in 4 
cases, and two patients refused to undergo the procedure. Altogether 16 patients 
had died before the 12-month MRI study was scheduled. 
Superficial brain retraction injury was more commonly (P<0.001) seen in 
surgical patients (n=21; 45%) than in endovascular patients (n=4; 10%) who had 
these lesions because of additional surgical treatments. Surgical patients also 
showed significantly more (P=0.018) ischemic lesions in the parent artery territory of 
the ruptured aneurysm (n=21; 45% vs. n=8; 20%), but not at remote locations (Table 
8). No statistically significant difference was found in the frequency of lesions caused 
by hematoma, lesions already present in the initial CT examination or in ventricular-
to-intracranial width ratios between the treatment groups (Table 8). 
In univariate analysis, ischemic lesions in the parent artery territory were 
associated with clinical symptoms of VSP (p=0.001). Ischemic lesions in other 
locations were associated with clinical symptoms of VSP (p<0.001), with higher 
Fisher grade (p=0.001) and with ischemic lesions in the parent artery territory 
(p=0.001). 
In univariate analysis, the following MRI variables revealed a significant 
association with poorer clinical outcome: size of the ischemic lesion in the parent 
artery territory (p<0.001) or in another location (p=0.001); presence of an ischemic 
lesion in the parent artery territory (p=0.003) or in another location (p=0.005); deficit 
due to preoperative intracerebral hematoma (p=0.035) and higher ventricular-
intracranial width ratio (p=0.040). These were included in a backward stepwise 
multiple logistic regression analysis as independent variables. In the final model, the 
presence of an ischemic lesion in the parent artery territory (OR, 6.20; 95% CI, 1.67 
to 23.05; p=0.006) and a deficit due to preoperative intracerebral hematoma (OR, 
4.23; 95% CI, 1.16 to 15.39; p=0.029) proved to be independent predictors of poorer 
clinical outcome. The R2 of the final model was 0.249. 
In contrast to the MRI findings in the whole study population, the 12-month MRI 
in the study IV population (n=40) revealed no significant difference in the number of 
ischemic deficits between the endovascular (n = 6 / 19) and surgical (n = 7 / 21) 
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groups but the mean size of the deficits was larger in the surgical group (P=0.018) 
(Table 3, Study IV).  
In the whole study IV population, dichotomized visual SPECT 2 findings (no 
deficit / visually detectable deficit) and MRI findings (no ischemic deficit / ischemic 
deficit) were used in the analysis of diagnostic accuracy of SPECT 2 in predicting late 
ischemic deficits. A visually detectable lesion in the second SPECT proved to have a 
sensitivity of 92% (95% CI, 78% to 100%), specificity of 26% (95% CI, 9% to 43%), 
PPV of 38% (95% CI, 21% to 54%), NPV of 86% (95% CI, 65% to 100%) and overall 
accuracy of 48% (95% CI, 32% to 63%) for a corresponding late ischemic deficit in 
MRI. The 2 x 2 contingency table used to calculate the diagnostic accuracy of 
SPECT in predicting late ischemic deficits is shown in Table 8, Study IV. 
 
14. Survival analysis 
 
Survival analysis is based on the data obtained by telephone interview in April 2000. 
All patients were included in the follow-up. There were no late rebleedings during the 
follow-up. There was no significant difference in cumulative survival times between 
the endovascular (mean survival time 1575 days, 95% CI, 1403 to 1746 days) and 
surgical (1572 days, 95% CI, 1400 to 1745 days) treatment groups (p=0.882). The 
patients with a preoperative Hunt&Hess grade I-II (1716 days, 95% CI, 1600 to 1832 
days) had a significantly lower risk of cumulative mortality (p=0.013) than the patients 
with grade III-V (1344 days, 95% CI, 1104 to 1583 days) (Figure 6). 
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DISCUSSION 
 
This is the first prospective randomized study to compare the outcomes of treatment 
of acutely ruptured intracranial aneurysms with either endovascular GDC occlusion or 
conventional open surgical neck clipping. The direct comparison between the 
previous observational studies of endovascular treatment (24, 27, 34, 145, 216, 285) 
and surgical clipping (96, 101, 135, 136, 198, 236, 238) of ruptured intracranial 
aneurysms is difficult because of the heterogeneity of the aneurysm and patient 
populations. The present study population in both treatment groups (Table 6) 
compares well with the populations of patients and aneurysms in previous large 
surgical and management outcome studies (101, 135, 136, 236, 238).  
 
1. Safety of the treatment  
 
There were more technical problems (17%) related to primary endovascular therapy 
than to surgical treatment (7%), and failure in attempting coiling was more common 
than failure in clipping. However, technique related morbidity (1.9% vs. 0.0%) and 
mortality (1.9% vs. 3.5%) were comparable in the endovascular and surgical groups. 
The procedure related morbidity and mortality figures in the present series are 
comparable with the figures reported in literature. In the previous endovascular series 
of patients with ruptured intracranial aneurysms, rates of 3.6% to 8.9% for morbidity 
and 1.7% to 6.4% for mortality have been reported (27, 34, 44, 145, 216, 285). 
However, direct comparison with the previous endovascular series is difficult because 
in those series patients with posterior circulation aneurysms were over-represented, 
as were aneurysms that were considered to be inoperable, some of those giant 
aneurysms. Furthermore, all aneurysms in the present study were treated within 3 
days following SAH unlike most aneurysms in the earlier endovascular series.  
In the surgical series with comparable patients populations, reported rates of 
technique related morbidity varied from 2.6% to 6.9% (101, 238) and mortality from 
2.6% to 3.9% (101, 198, 238). Some reports contain only combined figures of 
morbidity and mortality varying from 3.5% to 10 % (136, 236). The results in the 
present series compare favorable with the results in a recent prospective series 
where intraoperative complications in aneurysm surgery occurred in 30% of patients. 
Intraoperative aneurysm rupture accounted for 60% and inadvertent ligation of main 
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vessel 12% of all technical problems. Complications related to surgery accounted for 
27% of all morbidity and 8% of all deaths resulting in poor outcome in 7.9% of all 
patients (74). 
 
2. Feasibility of the selected treatment in the acute stage of subarachnoid 
hemorrhage 
 
The morphological criteria for inclusion to the study were liberal because we did not 
exclude the aneurysms with wide necks unless the dome-to-neck ratio was less than 
one. Others have recognized that in aneurysms with necks wider than 4 mm (62) or 
with dome-to-neck ratio less than two (44), complete occlusion is unlikely to be 
achieved. Even with our liberal inclusion criteria, it is apparent that with the current 
limitations of GDC treatment a ruptured aneurysm is more often suitable for surgical 
treatment than for coiling. The reason for excluding from randomization was large 
hematoma necessitating immediate evacuation in 35 of 242 patients with aneurysmal 
SAH (14%), aneurysm morphology not suitable for coiling in 33 patients (14 %), coil 
therapy not available in 6 patients (2%) and aneurysm causing a mass effect in 2 
patients (1%), whereas only 2 patients (1%) were excluded because the aneurysm 
was not considered feasible for clipping. Since only one exclusion criteria has been 
selected for each individual patient, there may be some overlap in the exclusion 
criteria applicable for individual patient. Thus, it is not possible to directly derive 
conclusions on how many of the excluded patients would have primarily been 
suitable for either treatment  
As a result of technical complications in the endovascular group, five patients 
(9.6%) underwent a crossover from the endovascular to the surgical group. 
Additionally in three cases (5.8%) coiling resulted in failure because the necks of the 
aneurysms proved to be too wide to retain the coils and the patients underwent 
subsequent surgical treatment. Only one patient (1.8%) with incompletely clipped 
aneurysm underwent crossover to endovascular group during the first hospitalization. 
Raftopoulos et al. (210) conducted a prospective analysis of the treatment 
options of 103 consecutive patients with 127 intracranial aneurysms; of those 59 
were ruptured. They considered endovascular treatment as a first option for all 
aneurysms. Predefined reasons for selecting surgical treatment were compressive 
hematoma necessitating surgical evacuation or unlikelihood to achieve a complete 
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coil occlusion (i.e. neck/sack ratio > 1:3). Only 64 (50%) of the aneurysms could be 
included to the endovascular group, the most frequent reasons for exclusion being 
wide neck in 27 aneurysms (21%), atheromatosis in 16 aneurysms (13%) and vessel 
leaving from the neck of the aneurysm in six aneurysms (5%). Finally the 
endovascular group contained more VBA aneurysms (14 versus 1), more ICA 
aneurysms (19 versus 12), less MCA aneurysms (19 versus 28) and fewer ACA 
aneurysms (12 versus 22) than the surgical group. 
The crossover rates in the study of Raftopoulos et al. (210) were approximately 
the same than in the present study with respect to both endovascular (16% versus 
15%) and surgical (2% versus 2%) groups respectively. Consistently with these 
results, in the series of Debrun et al. (44), coil therapy in 49 ruptured aneurysms 
initially selected for treatment on the basis of morphological criteria (dome-to-neck 
ratio at least 2 or absolute neck diameter less than 5 mm) was found to be unsuitable 
in 7 aneurysms (14%) and technical failure occurred in 3 aneurysms (6%) (44). Our 
finding that MCA aneurysms were seldom suitable for coiling (successful in only 3 of 
7) is consistent with the observation that configurations unfavorable to successful 
coiling include those locations where multiple branches arise, such as the MCA 
trifurcation. Giving the above figures, and assuming that in the present study the 
failure rate would have been equal if the patients randomized to the surgical group 
had instead been assigned for coil treatment and vice versa, it can be estimated that 
approximately half of the ruptured intracranial aneurysms seem to be suitable for 
coiling. 
In the series of Cognard et al. (34) of a total of 150 ruptured intracranial 
aneurysms smaller than 15 mm in diameter, 132 (88%) were successfully treated 
with GDCs. Lot et al. (165) reported a series of 395 consecutive cases of intracranial 
aneurysms (287 of those ruptured) managed either with GDCs, surgical clipping or 
both. Two hundred and ninety three (74%) of all aneurysms underwent coil treatment 
with 25 (9%) unsatisfactory occlusions. MCA was the only location for which more 
cases were treated by surgery than by coils. Only 2 aneurysms (1%) underwent 
crossover treatment to surgical clipping, whereas 21 unsatisfactory cases could be 
successfully treated with either re-embolization (n=19) or endovascular parent vessel 
occlusion (n=2). Furthermore, four of the seven failed surgical cases were 
successfully treated with coils. The differences detected in the feasibility of coil 
treatment between the French series (34, 165) and the present series as well as the 
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Raftopoulos series (210) may at least partly be explained by more active use of the 
“remodeling technique” (6, 166, 180) in treating the aneurysms with unfavorable 
geometry. 
 
3. Efficacy of the treatment 
 
3.1. Morphological results  
 
The overall initial aneurysm occlusion rates were significantly better in the surgical 
group than in the endovascular group. Only 50% of the endovascular patients had 
their aneurysms completely occluded, whereas 74% of the surgically clipped 
aneurysms were considered to be perfectly ligated. The rate of primary endovascular 
occlusion achieved is in accordance with the results from other endovascular series 
of ruptured intracranial aneurysms (20, 145, 187, 216). It is well known that the size 
and geometry of the aneurysm strongly affects the morphological result achieved by 
GDC treatment (44, 62, 108). In the present series of small aneurysms with a small 
neck, 61% were totally obliterated in the first session. Correspondingly, the initial total 
occlusion rate achieved in the small aneurysms (<10 mm) was 71% in the largest to 
date series of Vinuela et al (285). and 66% in the series of Byrne et al. (24). On the 
other hand, surgical occlusion rates in the present series were clearly worse than 
those reported by others. There were only 5% of incompletely clipped intracranial 
aneurysms in a recent systematic review of the surgical series (256). The difference 
may partly be explained by our strict policy in determining the morphological results 
of treatment. Even the slightest 1 to 2 mm “dog ear” was considered as a neck 
remnant. Such neck remnants may not be recognized on routine control angiograms 
(53, 55). Furthermore, postoperative control angiography is not routinely performed in 
many institutions. The few institutions having presented their excellent postoperative 
morphological results may not represent the average results achieved by surgery 
(39, 63, 160, 242).  
In the aneurysms located in the posterior circulation, the primary angiographic 
results were significantly better in the endovascular treatment group, whereas in the 
ACA aneurysms, the morphological results were significantly better in the surgical 
group. Posterior circulation aneurysms, especially distal basilar artery aneurysms are 
the easiest to reach from the endovascular route, thus a high success rate by 
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endovascular treatment in these aneurysms has been reported (60, 89, 157, 217). 
Aneurysms in posterior circulation represent less than 10% of an average aneurysm 
population (135, 236, 238), thus surgical experience in these cases is difficult to 
achieve. The best surgical results of VBA aneurysms in the literature, however, are 
superior to those achieved by GDC treatment (55). Configuration of the ACoA 
aneurysm may be angiographically difficult to define, although good and stable 
occlusion rates have also been achieved by coil occlusion in this location (35, 181). 
Pericallosal artery aneurysms have only anecdotally been described as being 
suitable for coiling (176). In the present series, the ACoA aneurysms and the 
pericallosal aneurysms were combined and analyzed as ACA aneurysms, which may 
influence the interpretation of the results. 
According to the intention to treat analysis, the final occlusion grades of the 
aneurysms after additional endovascular or surgical treatments were satisfactory in 
both treatment groups. In the surgical treatment group, 86% of the aneurysms were 
completely obliterated and 12 % were left with a small neck remnant, while in the 
endovascular group 77% of the aneurysms were completely occluded, 19% were left 
with a minor residual and in one aneurysm there were some residual filling of the 
fundus.  
 
3.2. Risk of rebleeding  
 
One early rebleeding occurred in an incompletely coil-occluded MCA aneurysm, and 
one intracerebral bleeding occurred in an anesthized patient, probably before the 
successful coiling of a MCA aneurysm. The latter event might have happened in a 
patient under general anesthesia before craniotomy as well. However, in that case it 
would have been possible to evacuate the hematoma without delay. In the patient in 
question, a hematoma was suspected because he woke up slowly and was found to 
be hemiparetic. Thus, there was an inevitable delay in the diagnosis of this 
hematoma, which perhaps had some influence on the poor outcome of the patient.  
An early rebleeding of a coiled ruptured aneurysm is rarely described in the 
endovascular literature. Byrne et al. (22) described one fatal rebleeding of 
incompletely occluded ICA bifurcation aneurysm 24 h after embolization. They have 
since then avoided staged procedures. In their report of the early treatment of 
patients in very poor condition after aneurysmal SAH, van Loom et al. (271) had 2 
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rebleedings (18%) in 11 coiled aneurysms. One rebleeding occurred at 5 days after 
an apparently complete occlusion of a large ICA aneurysm and the other event at 2 
months after SAH. They suggested that the earlier rebleeding was related to their 
prolonged postembolization heparinization (24h), which is at the present time rarely 
used. Although no rebleedings were detected among surgical patients with 
incomplete clipping, such events are occasionally seen after improper clip placement 
during the very first days after treatment. The frequency of that kind of event in 
general surgical population is unknown. Since control angiograms immediately or 
early after surgical clipping of the aneurysm are routinely performed only in a few 
institutions (256), it might be assumed that in endovascular patients with known 
occlusion rates after embolization, the risk of rebleeding would be easier to identify. 
However, the earlier described rebleeding 5 days after treatment (271) occurred in a 
supposedly totally occluded aneurysm, which makes the interpretation more difficult. 
No late rebleedings occurred in the present series during the follow-up. In their 
5-year follow-up study of ruptured intracranial aneurysms treated with GDCs, Byrne 
et al. (24) reported a rate of 7.9% of rebleeding in aneurysms with an unstable 
occlusion within a median of 22.3 months follow-up. The overall annual rebleeding 
rates were 0.8% in the first year, 0,6% in the second year, and 2,4% in the third year. 
Malish et al. (167) found a low risk of recurrent hemorrhage after successful coiling, 
whereas the risks for large and giant aneurysms were as high as 4 and 33%, 
respectively. Raymond et al. (216) observed subsequent rebleeding in 4 of 75 
patients after treatment of acutely ruptured intracranial aneurysms, 75% of 
rebleedings occurred in aneurysms that were initially incompletely occluded. In 
surgically treated intracranial aneurysms, the risk of hemorrhage of an aneurysm 
remnant is estimated to be 0.4% to 1.9% / year (39, 63). Tsutsumi et al. (263) 
calculated a 9.0% cumulative recurrence rate at 20 years after SAH. In their series, 2 
out of 6 rebleedings were from de novo aneurysms, which had not been visible in the 
original angiography. 
 
3.3. Refilling of the aneurysms and angiographic follow-up 
 
In the present series 1 of the 11 (9%) surgical neck remnants that were 
angiographically followed-up increased in size and 1 (9%) spontaneously 
thrombosed. Even the completely clipped aneurysms have been reported to regrow 
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in 1.5% to 2.4% of cases (39, 262). Others have reported regrowth from a surgical 
aneurysm rest in 5% to 25% of cases (39, 63, 262). However, the time interval from 
treatment to refilling has been suggested to be several years (39, 53, 55, 75, 262). 
Therefore, one-year control angiography was not scheduled for the patients with 
completely clipped aneurysms.  
The long-term stability of GDC occlusion is of some concern. In the present 
series refilling of the aneurysm occurred in 12 of 39 (31%) endovascularly treated 
patients during the first 12 months after initial embolization. Spontaneous thrombosis 
of the aneurysm remnant occurred in 7 of 39 (18%) cases. In one patient, the 
aneurysm remnant had spontaneously thrombosed in the three-month angiography, 
but was found to have recanalized in the 12-month angiography. Others have 
reported intracranial aneurysms with initial total occlusion after coil embolization to 
show a rate of 1.8% to 37% of refilling (24, 35, 44, 145, 187, 257). Recanalization of 
the incompletely occluded aneurysms has been reported to occur in 28% to 46% of 
cases (98, 257). Thus, results reported in literature are in accordance with the results 
achieved in the present series.  
Long-term angiographic follow-up (> 5 years after initial treatment) has been 
previously suggested for the patients with incompletely clipped aneurysms (53, 63, 
75, 160). Given the annual risk of 0.9% to 1.8% of de novo aneurysm formation (39, 
262), and the possibility of aneurysm regrowth after apparently complete clipping, 
late angiographic follow-up might be recommendable for young patients, even with 
complete clipping of the aneurysm. In the institution of Cognard et al. (36), the 
patients with total endovascular occlusion at second follow-up angiography (at least 
15 months after the procedure) are scheduled for final follow-up angiography 3 years 
thereafter. On the other hand, in patients with incomplete occlusion the angiography 
is repeated after 1 or 2 years depending on the morphology of the aneurysm rest. 
They consider it too premature to estimate when repeat angiography is no longer 
needed. Thornton et al. (257) recommend follow-up angiography at 6 months, 1 year, 
2 years, 4 or 5 years, and thereafter at different times when indicated. Ng et al. (187) 
were able to demonstrate a reduction from the overall recanalization rate of 27% 
during the first year to 20% over the second year to 14% over the third year. 
However, they suggested at least a 3-year angiographic follow-up for all coiled 
aneurysms. It is apparent that no consensus of the frequency of the angiographical 
follow-up needed can be obtained before there is more data available of the natural 
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history of the coiled aneurysms. A frequent angiographic follow-up inevitably causes 
high stress for the patient. The newly developed 3D-TOF MRA with postprocessing 
using targeted MIP reconstructions is promising noninvasive method for long-term 
monitoring of the stability of occluded aneurysms (19, 129). 
 
4. Aneurysm retreatment after embolization or surgical ligation 
 
Development of endovascular techniques and the current protocol of routine 
postoperative control angiography in surgically treated patients have lead to the 
frequent need for consideration of retreatment of partially occluded aneurysms. In the 
literature, the technical aspects of retreatment of surgically ligated aneurysms are 
well defined. Reoperations may be technically demanding at the acute stage of SAH 
because the brain is still tight and swollen and the acutely ruptured aneurysm still 
nonsecured due to improper previous clip placement. Increasing technical difficulties 
are encountered as the time interval from the initial operation to the reoperation 
increases because of scar formation. The complex anatomy and previously placed 
clips or material used in “wrapping” the aneurysms are factors that need to be 
considered in the planning of the reoperation (53, 75). In the present series, one 
patient had clip replacement during the primary hospitalization with a good outcome. 
However, in a second patient, resurgery 3 months after initial treatment resulted in a 
poor outcome, ultimately in death. 
Surgical ligation of the previously embolized aneurysms is often difficult with a 
risk of parent artery damage or occlusion. The coils may be incorporated into the 
vessel or aneurysm wall as soon as 2 week after coiling (110). Many authors suggest 
that there should be attempts to treat subtotally occluded or recanalized aneurysms 
initially treated with embolization with the same method before considering surgical 
treatment (91, 110, 165). However, this is not always possible because the geometry 
of the residual aneurysm cannot feasibly retain the coils. In the present series only 
three patients (6%) underwent reembolization. Surgical clipping of previously coiled 
aneurysm is technically difficult if the coils protrude to the neck of the aneurysm, 
hindering the proper clip placement over the neck. In such cases, some authors 
consider coil extraction as being necessary to enable the proper clip placement, thus 
favoring an early operation after the initial embolization (91, 110). Others suggest 
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delaying the operation beyond three weeks after embolization and clip placement 
over the coils in the aneurysm neck (30). 
In the present series 8 patients had early surgical treatment after incomplete or 
failed endovascular treatment without any major technical difficulties. Four patients 
underwent a delayed crossover from endovascular to surgical treatment. Additional 
surgical treatment was successful in three patients. However, in one patient, surgery 
one year after initial embolization resulted in fatal complications. Thus, surgical 
treatment of both previously clipped and embolized aneurysms in the present series 
was found to be risky. On the other hand, embolization of the residuals of 
incompletely clipped aneurysms was successful with no morbidity or mortality. These 
figures suggest that combined endovascular and surgical treatment may provide 
good anatomical results, however, with an increased risk of morbidity and mortality 
related to the delayed surgery. 
 
5. Clinical outcomes 
 
Although there was a trend towards better clinical outcomes in the endovascular 
group, the difference was not significant. The outcomes in both treatment groups are 
well comparable with the outcomes achieved in recent surgical series with 
comparable patient and aneurysm populations (101, 135, 236, 238). The comparison 
with the present series and the previous endovascular series is not straightforward 
because of the differences in timing of the treatment as well as in the aneurysm and 
patient populations (20, 34, 44, 145, 217, 285). Our main findings that the severity of 
the bleeding and the pre-treatment clinical condition of the patient are the major 
determinants for outcome are in accordance with the previous studies (136, 189). 
Although an individual not involved in the surgery or endovascular treatment (TK) 
performed the twelve-month clinical outcome evaluation, the clinical evaluation of 
outcome was complemented by subsequent neuropsychological evaluations and by 
late MRI study of the brain. 
 
5.1. Hydrocephalus  
 
Unexpectedly the endovascularly treated patients developed a chronic 
hydrocephalus significantly less frequently than the surgically treated patients. Three 
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patients (6%) in the endovascular treatment group and 11 patients (19%) in the 
surgical group developed a shunt-dependent hydrocephalus. The incidence of 
chronic hydrocephalus in the surgical group is clearly higher than the rate of 8% to 
10% reported in previous surgical series (135, 236, 252). Such a difference between 
the figures in the surgical and endovascular treatment groups in the present study 
might suggest that surgery itself somehow disturbs the normal cerebrospinal fluid 
flow. However, the previous retrospective studies comparing surgical and 
endovascular treatment of ruptured intracranial aneurysms have not detected 
differences in the frequency of chronic shunt-dependent hydrocephalus (83) or the 
frequency of interventions needed for treatment of hydrocephalus (240) between the 
treatment groups. In accordance with our results, Gruber et al. (83) found the 
frequency of chronic shunt-dependent hydrocephalus of 23% in their surgical 
treatment group. On the other hand the incidence of chronic hydrocephalus was 18% 
in the endovascular treatment group. These discrepant results may be explained by 
the relatively small number of patients examined in the present study. 
 
6. Twelve-month magnetic resonance imaging of the brain 
 
MRI is a sensitive method for detecting and characterizing permanent deficits in brain 
tissue as a consequence of SAH or treatment. A recent study showed that an 
unexpectedly large number of late MRI detectable lesions is found several years after 
treatment, especially in the frontal lobes among patients who undergo early surgery 
for aneurysmal SAH. All of these lesions cannot be revealed by CT (140). However, 
MRI findings do not necessarily correlate with the findings in neuropsychological tests 
(94, 226), although correlation of cognitive impairment and localization of cerebral 
infarcts in CT after clipping of ruptured intracranial aneurysms has been shown (283).  
Superficial brain retraction injury was frequently seen in surgical patients (n=21; 
45%). Four endovascular patients had these lesions because of additional surgical 
treatments. Surgical patients also showed significantly more ischemic lesions in the 
parent artery territory of the ruptured aneurysm (n=21; 45% vs. n=8; 20%), but not at 
remote locations. These findings suggest that surgical manipulation of the arteries 
does provoke local VSP leading to ischemic deficits, but surgery itself combined with 
rinsing of the basal cisterns neither produces nor prevents general VSP, as 
previously suggested (85).  
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The results in the present study are almost identical with the results in the study 
of Hadjivassiliou et al. (94) where surgically treated patients had a significantly higher 
incidence of MRI-detectable small infarcts within the parent artery territory, but 
endovascularly and surgically treated patients had equal incidences of large infarcts 
and global ischemic damage.  
 
7. Neuropsychological outcomes 
 
Being aware of the limitations of crude and subjective clinical estimation of outcome 
we employed a battery of standardized and widely used tests for neuropsychological 
evaluations. The importance of weighting outcome after SAH by neuropsychological 
factors has been emphasized after recognizing many patients with no clinical 
evidence of disability after SAH do suffer from subtle cognitive impairments (17, 115, 
162, 193). On the other hand, in some studies there have been few subtle signs of 
impairment of cognition and memory detected in patients with good neurological 
outcome (18, 174). In the present study, only a few patients with moderate or severe 
disability were able to perform all the neuropsychological tests. Thus, the comparison 
of scoring between treatment groups in these patients was not possible. Only 
patients with good clinical outcome were included in the final analysis of 
neuropsychological test scores. 
No difference in the neuropsychological test scores could be detected between 
the patients in the treatment groups. However, the patients in both groups improved 
their performance in many tests between the 3- and 12-month assessments, while 
the clinical outcome evaluation failed to show any improvement, indicating the value 
of neuropsychological evaluation. It is obvious that cognitive dysfunctions could have 
been found if the patients had been compared with individuals with no history of 
SAH. However, the aim of the present study was to determine the differences in 
neuropsychological outcome occurring after endovascular or surgical treatment of the 
intracranial aneurysms.  
It seems that the severity of initial SAH mainly determines the neurological and 
neuropsychological outcomes, explaining why the treatment groups showed similar 
patterns of impairment, as suggested by others (17). However, the paired case-
match study of Hadjivassiliou et al. (94) suggested that endovascular treatment might 
cause less MRI detectable structural brain damage than surgery. Furthermore, 
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endovascularly treated patients seemed to have a more favorable cognitive outcome 
based on comprehensive neuropsychological tests performed one year after 
treatment. The results in the present study might have shown a similar trend with a 
larger sample of patients since the presence of an ischemic lesion in the parent 
artery territory, more commonly found in the surgical group, proved to be an 
independent predictor of poorer clinical outcome. 
 
8. Future prospects in aneurysm treatment 
 
During the present study period, both the endovascular and surgical techniques 
remained stable, with the exception of introduction of the new “soft” GDC coils. 
Comparing the endovascular and surgical treatment modalities will probably be more 
difficult in the future because endovascular techniques are under constant and rapid 
evolution. Aneurysms with unfavorable geometry and morphology may be 
successfully treated with the remodeling technique of balloon assisted GDC 
placement (6, 156, 166, 180). The new generation of flexible stents allow more distal 
application in the intracranial vessels and tight coil packing through the stent (148, 
177). Endovascular coils with three-dimensional geometry (32), and neck-bridging 
devices (214) may improve long-term anatomic results through reduction in coil 
compaction and aneurysm re-formation. The biologically active covered coils or 
radioactive coils may accelerate aneurysm fibrosis and intensify neck neointima 
formation (2, 183, 184, 215). Embolization of wide-necked intracranial aneurysms 
with new liquid embolic agents combined with protective devices has proved useful in 
treating giant aneurysms previously considered unsuitable to coil endovascular 
treatment (170).  
The results of ongoing large randomized multicenter study of endovascular 
versus surgical treatment of ruptured intracranial aneurysms (ISAT) (179) will 
probably modify the future guidelines for treating ruptured aneurysms. The results of 
the present study and the development of the endovascular treatment have already 
modified the current protocol of aneurysm treatment in our own center. Three-D 
angiography has facilitated the evaluation of aneurysm morphology, especially the 
definition of the neck. If the aneurysm geometry is suitable for GDC-treatment, this 
modality of treatment is preferred in patients with posterior circulation aneurysms, in 
patients with very proximal carotid aneurysms, in patients with poor Hunt&Hess 
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grades (Gr IV-V) or with severe illnesses, and in elderly patients with no definite age 
limit. However, in most aneurysms, surgical ligation is still considered to be the 
treatment of choice. In the subgroup of patients with complex aneurysm geometry 
and a high risk related to surgery, endovascular treatment with “remodeling”-
technique or stenting with or without coiling is considered. Sometimes combined 
endovascular and surgical treatment (staged procedure) is considered as the best 
option for treatment.  
The evolution of surgical treatment is not as expeditious since the surgical 
standards have bee developed during several decades achieving their current high 
standards (289, 290). However, one important issue will be how to maintain the 
surgical expertise. Interventional neuroradiologists are gaining experience and thus 
an increasing number of aneurysms will be treated by endovascular means. The 
ones left for open surgical treatment are those with most complex anatomy, or those 
having already undergone failed endovascular treatment. One possible way to 
improve surgical results might be reserving open surgery to the care of microvascular 
subspecialists. Endovascular therapists do not touch the brain, and those continuing 
to perform open microsurgery should be able to do nearly so with atraumatic 
techniques. The current impressions and opinions in the literature of the limitations 
and advantages of endovascular or surgical treatment of ruptured intracranial 
aneurysms are presented in Table 12. 
 
9. Medical complications and splanchnic tissue perfusion after subarachnoid 
hemorrhage 
 
Medical complications after aneurysmal SAH may significantly contribute to the 
overall mortality rate (101, 149, 244, 293). Gruber et al. (84) noted a 29% SIRS rate 
among SAH patients and found that 77% of extracerebral organ system failures 
(OSFs) occurred in conjunction with SIRS. The mortality rate was 40.2% in patients 
with systemic inflammatory response syndrome (SIRS). The results were in 
accordance with a recent study by Yoshimoto et al. (293) who also stated that there 
was an association between admission SIRS score and subsequent neurological 
deterioration. These findings gave rise to speculation that some mechanism of 
central dysregulation secondary to intracranial aneurysm rupture could contribute to 
the development and progression of extracerebral organ dysfunction by promoting a 
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state of systemic inflammation with the potential for systemic organ dysfunction (84, 
293). In the present study, 23% of the patients had extracerebral complications 
during their ICU stay. However, the number of patients was small. Therefore, it is 
difficult to compare the type and rate of complications in the present study with the 
complications reported in other related studies.
 
Table 12. Current impressions and opinions in the literature of the limitations and 
advantages of endovascular or surgical treatment of ruptured intracranial aneurysms. 
 
Feature Endovascular treatment Surgical treatment 
   
Safety + + + + 
Morphological aneurysm  
occlusion 
+ ++ 
Short term efficacy  
in preventing rebleeding 
+ + + + + 
Shown long term efficacy  
in preventing rebleeding 
+ + + 
Applicability in aneurysms 
with complex geometry 
- / + - / + 
Applicability in 
posterior circulation aneurysms 
+ + + + + 
Applicability in 
anterior circulation aneurysms 
+ + + + + 
Need for angiographic 
follow-up 
- - + 
Cost (including the follow-up) - - - 
Availability + + + + + 
Learning curve duration - - - - - 
Stress for the patient + + - 
Evolution of the technique + + + - 
 
Note:  + means minor benefit, ++ moderate benefit and +++ remarkable benefit 
- means minor limitation, - - moderate limitation and - - - remarkable limitation 
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9.1. Splanchnic tissue perfusion, assessed by gastric tonometry  
 
Insufficient splanchnic tissue perfusion has been regarded as one of the possible 
mechanisms responsible for the SIRS (7) and multiple organ dysfunction syndrome 
(155). Pulmonary dysfunction caused either by central dysregulation and high-
permeability pulmonary edema or by secondary aspiration pneumonia is one of the 
most common organ dysfunctions related to SAH (84, 244). Although SAH patients 
commonly present with hypovolemia (186), the volume correction under these 
circumstances is difficult. Further, high levels of catecholamine in plasma have been 
found in patients with SAH (47). Increased levels of catecholamines or cytokines may 
cause vasoconstriction in the splanchnic area and lead to deterioration of splanchnic 
tissue perfusion (241, 279).  
Although splanchnic hypoperfusion may be induced by central dysregulation, 
correlating with the severity of the CNS trauma in acute low flow states, splanchnic 
blood volume and flow redistributes from less vital to vital organs such as heart and 
the brain (56, 155). Therefore gastrointestinal hypoperfusion may be the first sign of 
insufficient systemic oxygen delivery and in fact may reflect the neurological 
deterioration. There is evidence that splanchnic ischemia occurs commonly in 
isolated neurotrauma, there being a trend toward development of mucosal ischemia 
with decreased cerebral perfusion (279). However, there are no studies about this 
issue in the patients with SAH. 
The mean values (± SD) of pCO2 gap in the grouped data of the present study 
were 1.5±1.9 kPa and 1.7±1.2 at the time of the first and the second measurements, 
respectively. These results suggest that splanchnic tissue perfusion may be 
insufficient after SAH. The proposed upper limits for a normal pCO2 gap have varied 
from 1.2 kPa (141), to values as high as 3.2 kPa in healthy volunteers (119). 
Although plasma levels of norepinephrine or epinephrine correlate with the severity of 
SAH (21, 47), we found no correlation between the pCO2 gap and the severity of 
hemorrhage. There was also no difference in the levels of pCO2 gap between the two 
treatment groups. However, the results are in accordance with the study by 
Venkatesh (279). They found no clear correlation between the development of 
mucosal ischemia and the decrease in cerebral perfusion in patients with traumatic 
brain injury. 
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Several problems accompanied this substudy. First of all, a high number of 
patients could not tolerate the stiff nasogastric tube, and thus the majority of the 
patients enrolled to the randomized study could not be included in this substudy. 
Although the aim of this substudy was to evaluate the early response of SAH and the 
modality of treatment on splanchnic tissue perfusion, the time period for 
measurements was too short to detect the changes in the pCO2 gap, possibly 
occurring with the post-treatment clinical deterioration frequently observed during the 
ICU treatment. Furthermore, there are several problems associated with pHi 
measurements. The measurements of PCO2 from saline samples can introduce 
errors in pHi values because of the low stability of PCO2 in saline and the extensive 
variation in the quality of the different gas analyzers (222, 249). Due to the 
equilibration period needed, rapid changes in splanchnic tissue perfusion cannot be 
promptly detected (155). These drawbacks could be avoided by applying a new 
automated gas tonometric technique (37). 
 
10. Vasospasm and cerebral perfusion 
 
In the present study the incidence of symptoms that were regarded as probable 
symptoms of VSP did not significantly differ between the treatment groups. However, 
only in half of the patients in both treatment groups were the symptoms of VSP 
considered to be definitely absent. Although the incidence of probable or possible 
VSP was high, these findings are in accordance with the incidence of VSP reported 
in previous surgical series (135, 236). Recent endovascular series have reported 
somewhat lower frequencies of 21% to 23% of VSP (182, 216). The nonrandomized 
series by Gruber et al. (85) comparing treatment of acutely rupture intracranial 
aneurysms by GDC coils or surgical neck clipping found a higher incidence of 
delayed ischemic infarctions in the endovascular treatment group. However, the 
treatment groups were imbalanced, and in patients with Fisher grade 3, where the 
treatment groups were comparable, the endovascularly treated patients had fewer 
infarcts. 
The diagnosis of VSP should be accurately set at the very early phase of VSP 
when the ischemic changes still can be reversed e.g. by the application of the “Triple-
H therapy” (10, 132, 197) or balloon angioplasty (58, 69, 151, 159, 204). Since the 
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clinical diagnosis of VSP is based on the time of onset, the nature and course of the 
deficits, and the exclusion of other factors that may cause gradual deterioration of the 
patient or focal neurological signs (133), it is difficult to define in patients with 
impaired consciousness (48, 144, 152). Angiography is the standard method for 
assessing the degree of arterial narrowing caused by cerebral VSP (70), however it 
is invasive with a risk for permanent complications (31). A TCD technique has been 
proposed for noninvasive evaluation of cerebral VSP (1). On the other hand, TCD or 
angiography do not directly address the effects of VSP on the rCBF in the associated 
vascular territories (33, 41, 69).  
It has been shown that after SAH there is a fall in cerebral blood flow to a 
degree which depends on the severity of VSP (120, 288). Powers et al. (206) were 
able to demonstrate a range of rCBF for reversible ischemia (12 ml/ 100g/ min < CBF 
< 20 ml/ 100 g/ min) and irreversible infarction (CBF ≤ 12 ml/ 100 g/ min). However, 
the authors suggest that cerebral VSP is not a static process, thus it may be 
impossible to set absolutely consistent thresholds for reversible ischemia and 
irreversible infarction. Therefore there may not be a need for quantitative 
measurements of CBF after SAH. Detection of the existence of disturbances in 
cerebral perfusion might help to identify those patients who are at risk for developing 
DID.  
 
10.1. Cerebral perfusion before and after treatment, assessed by single photon 
emission tomography 
 
SPECT is widely available and in clinical use, it has provided useful data for 
detecting VSP (40, 207, 245). In the present study it was decided to use SPECT as a 
qualitative method for detecting the differences in cerebral perfusion occurring before 
and after endovascular or surgical treatment of ruptured aneurysms. The original 
idea was to use the first SPECT study as a baseline study in which disturbances in 
cerebral perfusion caused either by VSP or treatment would not yet have developed. 
Perfusion deficits were frequently seen before treatment. In the SPECT performed 
before treatment, there were only 5 (20.8%) patients without cerebral perfusion 
deficits in the surgical treatment group and 8 (36.4%) patients in the endovascular 
group. Another study found that the reduction in CBF and CMRO occurred at the 
very early stage of SAH possibly as a consequence of elevated ICP at the time of 
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aneurysm rupture (99). Other possible causes for early CBF reduction after SAH may 
be early microvascular vasoconstriction (15), hydrocephalus (97) or reduced 
metabolic demands of the brain because of the initial effects of SAH on brain tissue 
(25, 81, 286). Thus, our observation of a variety of abnormalities in the first SPECT is 
in agreement with the findings reported in the literature. 
In the visual comparison between the first and second SPECT, the number of 
new or enlarged deficits, and deficits which expanded from being unilateral to 
bilateral significantly increased in the surgical group. The comparison between the 
first and second SPECT revealed significant decreases in cortico-cerebellar 
perfusion ratios (CCRs): in the right frontobasal cortex, right frontal cortex and right 
pericallosal area in the surgical group. In the second SPECT, surgical patients had 
decreased CCRs in the right frontobasal cortex when compared to the endovascular 
patients and in the ipsilateral frontobasal cortex and ipsilateral temporal when 
compared to contralateral side of the ruptured aneurysm. These findings, not 
demonstrated in the endovascular group, suggest that surgery has a greater impact 
on cerebral perfusion than endovascular treatment. Although most of the perfusion 
deficits seen in the second SPECT were transient and not detectable in the late MRI 
of the brain, the results in the present study are in accordance with the results in the 
study by Hadjivassiliou et al. (94), where endovascular treatment was found to cause 
less permanent structural brain damage than surgical treatment. 
Many authors have detected decreased perfusion near the site of the ligated 
aneurysm not correlating with the patients’ neurological condition, possibly being 
related to the use of brain retractors or just manipulation of the brain causing 
postoperative edema (111, 112, 232). Hosono et al. (112) found disturbances in 
cerebral perfusion near the operative site in 29 of the consecutive 35 patients with 
SAH already on day 1 after surgery. Only the deficits which appeared newly on day 7 
after surgery were considered to be caused by VSP. A similar interpretation of the 
SPECT studies was suggested by Rosen et al. (232) who found abnormalities of 
rCBF observed near the operative site in 17 of 20 SPECT studies, performed on 
patients without clinical VSP. According to these workers, only rCBF abnormalities 
remote from the operative site should be interpreted as indicating VSP. The 
postoperative decreases in perfusion in the ROIs of temporal apex and frontobasal 
cortex ipsilateral to the ligated aneurysm might have been caused by surgical 
manipulation. However in the visual interpretation, the abnormal findings were 
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bilateral in 14 (64%) of the 22 abnormal SPECT studies in the surgical group 
indicative of global VSP in conjunction with the changes possibly caused by surgical 
manipulation. In the present study many of the perfusion deficits near the operative 
site were seen already before treatment. Furthermore, surgically treated patients 
commonly developed permanent ischemic deficits in the vascular territory of the 
parent artery. This may indicate that some of the regions of diminished postoperative 
perfusion in the frontal and temporal lobes probably have been caused by VSP, 
although not distinguished from the deficits with other etiology. Acute hydrocephalus 
may explain some findings, especially in the basal parts of the brain (97), but we 
could not confirm that hypothesis. 
 
10.2. Vasospasm and single photon emission tomography  
 
Good correlation between postoperative changes in SPECT and the occurrence of 
VSP has been demonstrated in many studies (40, 41, 207, 245, 259). In the present 
study, we could not ensure the proximity of SPECT and the onset of clinical VSP. 
However, the visually evaluated SPECT proved to have good sensitivity (96%), but 
low specificity (55%) for clinical VSP. These results are in accordance with the results 
achieved in previous studies (sensitivity of 85% to 89% and specificity of 71% to 
88%), indicating that SPECT could accurately corroborate the clinical suspicion of 
VSP (41, 207). Discordantly with the results in most studies, Hosono et al. (112) 
found visual interpretation of TCD-SPECT to have a very low sensitivity (33%) in 
indicating VSP confirmed by angiography or CT. On the other hand, they found 
noninvasive measurement of mean CBF (decrease over 10% between the two 
studies) using 99mTc-ECD as a tracer to indicate VSP with good sensitivity (78%) and 
specificity (89%). The discordant results may partly be explained by the fact that in 
visual interpretation of the results they considered only the newly developed deficits 
between the SPECT studies performed on day 1 and 7 after SAH as being indicative 
of VSP.  
According to the results of the present study, static SPECT may not be very 
useful for routine guidance in the treatment of patients with aneurysmal SAH, 
although it may rule out VSP in some problematic cases. Recognition that 
parenchymal vessels distal to arteries with angiographic spasm after SAH do not 
show normal autoregulatory vasodilatation (206, 294), has encouraged authors to 
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devise dynamic studies utilizing SPECT or other qualitative methods to identify 
patients at increased risk for DID. Acetazolamide challenge of the cerebrovascular 
reserve as studied by SPECT has been accurately found to preclude the patients 
with clinically irrelevant deficits in cerebral perfusion (138). However with the current 
limitations, dynamic SPECT cannot serve as a real bedside method for observation 
of the patients during the time course of VSP. A transient hyperemic response test 
(THRT) in conjunction with the TCD evaluation may provide a simple, noninvasive 
bedside technique for frequent examination of the autoregulatory reserve in SAH 
patients (147, 213). A promising new, although invasive, method for bedside 
monitoring of brain ischemia is intracerebral microdialysis. Nilson et al. (188) found 
that changes in extracellular biochemical parameters actually preceded both the 
increased blood flow velocities as measured by TCD and the subsequent clinical 
deterioration of the patient.  
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CONCLUSIONS 
 
1. Endovascular treatment of acutely ruptured intracranial aneurysms with GDC coils 
is technically feasible in a selected group of patients with the procedure related 
morbidity and mortality rates equal to those seen with surgical ligation. However, 
failure in coil treatment is more common than failure in surgical clipping, thus 
subsequent surgical treatment is frequently required. Surgery provides better primary 
angiographic occlusion rates in most anterior circulation aneurysms while aneurysms 
in posterior circulation are better treated with coils.  
 
2. The severity of the initial SAH is the most important factor determining the 
outcome of the patients. Although endovascular treatment is less often associated 
with MRI-detectable brain injury, both modalities of treatment result in equal clinical 
and neuropsychological outcomes. Angiographic follow-up reveals often unstable 
occlusion in the endovascularly treated intracranial aneurysms. Thus, the long-term 
efficacy of endovascular treatment in preventing rebleeding remains open. 
Developments in endovascular techniques may improve the morphological results 
and reduce the frequency and need for angiographic follow-up. 
 
3. Splanchnic tissue perfusion, as assessed by gastric tonometry, may be 
insufficient after SAH. However, neither surgical or endovascular treatment nor the 
severity of initial SAH seem to affect splanchnic tissue perfusion as evaluated by 
measuring the pCO2 gap. Use of gastric tonometry as a therapeutic tool in SAH 
patients cannot be recommended without a further development in technique. 
 
4. Disturbances in regional cerebral perfusion both before and after treatment of 
ruptured intracranial aneurysms are common as evaluated by ECD-SPECT. 
Progression of perfusion deficits was more common in the surgical group. However, 
the clinical importance of these findings is unclear since MRI of the brain revealed an 
equal number of ischemic deficits in the treatment groups. Although SPECT findings 
are associated with clinical VSP and late ischemic deficits on MRI, the positive 
predictive value of SPECT is low.  
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